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v i z . 1 ,3-d i ( 2 - m e t h y l p h e n y l ) - , l , 3 - d i p h e n y l - , 1 ,3-di (4-chloropheny 1)-
1 ,3-d i ( 2 - m e t h o x y p h e n y l ) - l , 3 -d ihyd ro -2 - th ioxo -2H. 5H-pyr imidine-4 , 
6-diones gave the corresponding benzopyranopyr imid ines (44b-f) and 
t h e i r s t r uc tu r e s were formulated on the b a s i s of s p e c t r a l data and 
elemental a n a l y s i s . A mechanism for the react ion has also been 
p roposed . 
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CHAPTER II: Synthesis of 1 , 3 - d i a r y l - l , 3 -d ihydro-5- (2-subs i tuted 
th lazo l -4 -y l ) -2 - th ioxo-2H, 5H-pyrlmidine-4, 6-dlones 
The biologica l and t h e r a p e u t i c p r o p e r t i e s of th i azo le and i t s d e r i v a t i v e s 
has been wel l e s t a b l i s h e d . Th i s prompted the inves t igat ion of new 
routes for the s y n t h e s i s of these d e r i v a t i v e s . Some general methods 
for the s y n t h e s i s of th i azo les and t h e i r phys io log ica l p r o p e r t i e s have 
been d i s cus sed . In o r d e r to e s t a b l i s h s t r u c t u r e - a c t i v i t y r e l a t ionsh ip 
some new d e r i v a t i v e s possess ing py r imid ine moiety have been 
s y n t h e s l s e d . A faci le method for the s y n t h e s i s of 1, 3 - d i a r y l - l , 3 -
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dihydro-5-(2-mercaptothiazol-4-yl)-2-thioxo-2H, 5Hi>\}riinidine 4,6-diones 
(61a-f) and 1,3-dlaryl- l , 3-dihydro-5-(2-inethylthiazol-4-yl)-2-thioxo-
2H, 5H-pyriniidine-4, 6-dlones (62a-f) has been worked out. The method 
involves the reaction of 1-phenyl, 3-aryl-2-thlo barbituric acids with 
chloroacetyl chloride to give intermediate chloroacetyl derivative. This 
on further condensation with ammonium dlthiocarbamate or thioacetamide 
gave the desired 2-mercapto or 2-methyl thlazole derivative 
respect ively. 
As a typical case, 1-phenyl, 3(2-methylphenyl) thlobarbiturlc 
acid was treated with equimolar quantities of chloroacetyl chloride to 
give 5-chloroacetyl-l - phenyl, 3(2-methyl)-2-thiobat'bituric acid. 
This on further condensation with ammonium dlthiocarbamate in absolute 
ethanol afforded a solid product in good yield. The product gave a 
negative DNP test and i t s H-NMR spectral data showed a sinplet for 
a D O exchangeable proton at J 5.4 which was assigned to the -SH 
group of the thiazole ring besides other expected signals. Further 
the mercaptothlazole was converted into i t s S-methyl derivative. Based 
on the spectral data and elemental analysis the compound was 
characterised as l -phenyl-3-(2-methylphenyl)- l , 3-dlhydro-5-(2-
mercaptothiazol-4-yl)-2-thioxo-2H, 5H-pyrldlmlne-4, 6-dlone (61a). 
Similarly the compounds (61b-f) were syntheslsed by the 
reaction of appropriate chloroacetyl thlobarbiturlc acid derivative with 
ammonium dlthiocarbamate. 
The syntheses of 1 ,3-diaryl- l , 3-dihydro-5-(2-methylthlazol-
4-yl)-2-thloxo-2H,5H-pyrlmldine-4,6-diones {62a-f) were achieved in 
a similar manner by the condensation of corresponding S-chloroacetyl-
thlobarblturic acids with thioacetamide in absolute ethanol. All the 
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compounds s y n t h e s i s e d were c h a r a c t e r i s e d by t h e i r s p e c t r a l data and 
e lementa l a n a l y s i s . 
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CHAPTER III: Sjmthesis of 5 - h y d r o x y - l , 3 - d i a r y l - l , 2 , 3 , 4 , 5 - p e n t a h y d r o -
10-methyl-4-oxo-2-thioxopyridi inido (4 , 5-b) quinoline 
A number of py r imid ines assoc ia ted with p y r i d i n e and quinoline 
a r e we l l known for t h e i r importance in b io log ica l f i e ld . Some methods 
to s y n t h e s i s pyr imidoquinol ines have been i l l u s t r a t e d . Keeping in view 
- 5 -
the physiological and biological importance of such compounds it was 
considered of interest to synthesise pyrimidoquinoUnethiones by a 
convenient route. 1 ,3-d iary l - l , 3-dihydro-6-chloro-5-formy 1-2-thioxo-
2H, 5H-pyrimidine-4, 6-diones (26a-f) were synthesised and further 
condensed with N-methyl aniline to give 5-hydroxy- l , 3-diary 1 -1^ ,3 , 
4,5-pentahydro-10^methyl-4--^DXo-2-thloxopyrir'iido(4,5-b) quinolines(28a-f) .In 
the H-NMR spectrum a IH singlet at 65.4 was assigned to the 5-H. 
Other signals were observed at expected values. Presence of the 
hydroxy group was confirmed by I.R spectra and derivatisation with 
A c , 0 / P y . On the basis of spect ra l data and elemental analysis , the 
structures of the t i t l e compounds were established . 
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CHAPTER IV : Synthesis of 5-ary]ldenethiobarbituric acids, 
S-fpyrimidinyl) inethylidene-2-thiobarbituric acids and 1,3-diaryl 
pyranodipyrimidines as possible redox coenzyme model 
A brief account of the importance of redox coenzymes and their mode 
of action has been given. The importance of 5-ylidene barbituric 
acids , which incorporate the necessary functionality i . e . >C=C< flanked 
by electron withdrawing groups comparable to the redox coenzymes, 
has been discussed along with methods of their preparation and their 
biological ac t iv i t ies . Synthesis of compounds 1, 3-diaryl-5-arylidene-
2-thiobarbituric acids (22a-f), 5-^yrimidinyl) methylidene-2-thiobarbi-
turic acid (25a-f) and 1, 3-diaryl pyranodipyrimidines (27a-f) 
described in PART-A, PART-B and PART-C respect ively, has been 
undertaken in view of their structural similari t ies with redox 
coenzymes. 
PART-A: The method involves the condensation of different l ,3 -d iary l=-
2-thiobarbituric acids with nitrobenzaldehyde. The reaction of 1,3-
di (2-methylphenyl)-2-thiobarbituric acid with 0-nitrobenzaldehyde gave 
a white solid, characterised by i t s H-NMR , mass spectral data and 
elemental analysis as 1,3-di (2-methylphenyl)-5- (2-nitrobenzylidene)-
2-thiobarbituric acid (22a). Similarly compounds (22b-f) were 
synthesised and characterised by spectral and elemental analysis . 
PART B: This series involves the condensation of l ,3 -d ia ry l -2- th iobar -
bituric acids with 6-chloro-l , 3-di (4-bromophenyl)-5-formyl-2-thioura-
c i l to give a solid characterised as 5-C6-chloro-li 3 ' -d i (4" 
-bromophaiyl)-2- thiouraci l -5 ' -yl) methyl idene-1, 3-diaryl-2-thiobarbi -
turic acid (25a-f] by thei r 'H-NMR, I.R. and elemental analysis. 
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PART C : The condesation of unsubsituted 2-thiobarbituric acid with 
different 6-chloro-l , 3-diaryl-5-formyl-2-thiouracil gave 7, 
9-diarylpyrano(2,3-d:6,5-d) dipyrimidine-2((lH), 8 (lOH) dithioxo,4 
(3H), 6(7H) dione (27a-f). The I.R. spectra showed NH absorption 
-1 
at 3400 cm . In the H-NMR spectrum the 5-H was discernible at 
values ranging from ^8.9 to<?9.1 besides other expected signals. On 
the basis of spect ra l data and elemental analysis the structures were 
characterised as above. 
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SUMMARY 
CHAPTER I: One step synthesis of l ,3 -dlaryl -5- ( l ' ,3 ' -d iaryl -6- 'hydroxy-
4' -oxo-1 •, 2 ' , 3 •. 4 • -tetrahydro-2 • -thioxo-5' -pyrlmidlny 1) -1,2,3,4-tetra-
hydro-2-thioxo-4H-|l | -braizopymno [2,3-d]-pyriiiildln-4-one. 
Pyrimidine and i t s derivat ives have been extensively investigated by 
organic chemists due to their close association with life processes. 
Association of significant biological and physiological act ivi t ies with 
these compounds led to the synthesis of a number of their derivat ives. 
A brief account of their uses, biological act ivi t ies and methods of 
preparation has been given. An efficient one pot synthesis of 
benzopyranopyrimidines has been developed. It involves the reaction 
of different 1,3-diaryl thiobarblturic acids with salicylaldehyde in 
methanol and a few drops of cone. HCl. 
Thus, as a test case, the reaction of l ,3-di{4~methylphenyl)-
2-thiobarbituric acid with salicylaldehyde in the ratio of 2:1 In 
methanol and HCl at reflux temperature resulted in the formation of 
a solid product in good yie ld . Its 'H-NMR spectrum showed a singlet 
at&4.5 for the hydroxylic proton and a IH singlet a tS5.4 assigned to 
H-5. 
The spectral data and elemental analysis confirmed the 
structure of the product as l ,3-di(4-methylpheny l ) - 5 - ( l ' ,3 ' -di(4-methy ]-
pheny 1 ) -6 ' -hydroxy-4 ' -oxo-1 ' , 2 ' , 3 ' ,4 ' - tetrahydro-2 ' thioxo-5 '-pyrlmidlnyI) 
- l ,2 ,3 ,4- te t rahydro-2- th ioxo-4H-[ l ] -benzopyraio [2,3-d] -pyrimidin-4-or.c 
(44a}. Similar condensation with other 1,3-diary Ithiobarbituric acids 
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PREFACE 
Pyrimidine and substances with fused pyrimidine 
ring such as purines, pteridines etc. play an important 
role in the biochemistry of life processes. The 
barbiturates and their sulphur analogues are also 
pyrimidine derivatives, which have gained importance iii 
the pharmaceutical field because of the various 
interesting biological properties of this system. 
Ben"2opyrano pyrimidine's viz 1,3-diaryl-5-( 1,3-
diaryl-6-hydroxy-4-oxo-l', 2', 3', 4-tetrahydro-2-thioxo-5-
pyrimidinylY 1,2,3,4-tetrahydro-2-thioxo-4H-(1)-benzo 
pyrano (2,3-d) pyrimidine-4-one have been synthesised in 
one step involving the reaction of 1,3-diaryl 
thiobarbituric acids with salicylaldehyde in methanol in 
presence of hydrochloric acid. 
The therapeutic actions of thiazoles directed 
attention towards their synthesis and investigation of 
the structure-activity relationships. A convenient 
synthesis of 1,3-diaryl-l,3-dihydro-2-thioxo-5-( 2-
mercaptothiazol-4-yl)-2H, 5H-pyrimidine-4, 6, diones and 
1, 3-diaryl-l, 3-dihydro-2-thioxo-5-(2-methylthiazol-4-yl) 
2H, 5H-pyrimidine-4, 6-diones has been carried out. The 
method involves the reaction of 1,3-diaryl thiobarbituric 
acid with chloroacetyl chloride in presence of 
triethylamine to give an intermediate which on further 
condensation with ammonixim dithiocarbamate or 
thioacetamide in absolute ethanol gives the desired 
mercapto or methyl thiazoles respectively. 
A number of pyrimido quinolines were synthesised 
by a convenient route. This involved the condensation of 
6-chloro-l,3-diaryl-5-formyl - 2-thiouracil with 
N-methylaniline to give 5-hydroxy-l,3-diaryl, 1,2,3,4,5-
pentahydro-10-methyl-4-oxo-2-thioxopyrimido (4,5-b) 
quinoline. 
Redox coenzymes, specially flavins which contain 
pyrimidine ring, have become the subject of active 
research due to their ability to oxidise alcohols to the 
corresponding carbonyl compounds. Compounds like 
5-arylidene and 5-alkylidene derivatives of pyrimidines 
having been employed for the synthesis of a number of 
physiologically active compounds, have also shown the 
potential towards nucleophilic attack suggesting their 
use as model compounds for redox coenzymes. Hence the 
synthesis of 5-arylidene thiobarbituric acids and 
5-(pyrimidinyl) methylidene thiobarbituric acids have 
been undertaken, which involved the reaction of 
1,3-diaryl thiobarbituric acids with benzaldehydes and 
6-chloro-l,3-diaryl-5-formyl-2-thiouracils respectively. 
This further led to the synthesis of 7,9-diaryl pyrano 
(2,3-d : 6,5-d) dipyrimidine-2 (IH), 8 (lOH) dithioxo, 
4(3H) 6(7H) dione by the condensation of 6-chloro-l,3-
diaryl-5-formyl-2-thiouracil with unsubstituted 
thiobarbituric acids. It is likely that due to their 
structural similarities with well known redox coenzymes, 
these compounds may be used as model compounds for redox 
coenzymes. 
Notes 
Melting points have been taken in sulphuric acid bath and 
are uncorrected. I.R. spectra were recorded on Perkin 
Elmer Grating infrared Spectrophotometer, Model 621 and 
F.T.I.R. Spectra were recorded on Perkin Elmer Infrared 
Spectrophotometer, Model 1600. H-NMR spectra were 
recorded on Perkin Elmer R-32 (90 MH?) spectrometer 
(splitting patterns, coupling constants, integration of a 
particular signal and assignement of the signals are 
given). U.V. spectra (uv-visible) were recorded on 
Perkin Elmer Spectrophotometer, Model 644, and U.V./vis 
spectrophotometer model 260 shimadzu. Notation used are 
as follov/s : S-singlet, bi?s-broad singlet, d-doublet, 
t-triplet, q-quarlet, m-multiplet. Elemental (C, H&N) 
analysis was carried out on Heraeus CHN-Rapid analyser. 
Petroleum ether used as 60-80° boiling fraction. 
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CHAPTER - I 
One step synthesis of l,3-diaryl-5-(l,3-diaryl-6--hydroxy-
4-oxo-l,2,3,4-tetrahydro-2-thioxo-5-pyrimidinyl)-1,2,3,4-
tetrahydro-2-thioxo-4H-[1]-benzopyrano[2,3-d]pyrimidines-
4-one 
Introduction 
The chemistry of pyrimidine trione, commonly known 
as barbituric acid (1) and its derivatives has been 
studied for over a century. Therapeutic value of 
barbital i.e. 5,-5-diethylbarbituric acid (2) as a 
hypnotic agent was reported in 1903 and since then 
constant progress in their chemical and pharmacological 
studies has been reported. 
Barbituric acid has two active hydrogen atoms at 
the 5-position v/hich can be replaced by various 
substituents to make other biologically active 
9 — fi 
molecules . The introduction of simple alkyl 
substituents to this position give the 5-alkyl 
substituted barbituric acids (3) which have been reported 
7 8 
as hypnotic agents ' , 
H H H 
Q^^V^ O ^ N ^ Q>-^KP 
wrli r ,J, /Et .J, HN H HN. 0 y Et -^y^ci^,NHP. 
(1) (2) (3) 
It is found that the thio analogues of barbituric 
9 
acids act as superior hypnotic agents 
(4) is being used as a quick acting anaesthetic 
Thus thiopental 
10 
Its 
other derivatives (5) are associated with antiDacterial 
11 
activities' 
H 
HN L^ 
^ H 4 , M . 
4, R = ethyl 
5, R = alkyl 
(4,5) 
Aryl substitution at position 1 and 3 resulted in the 
formation of compounds of type (6) v/hich have been 
. . 12 
reported to possess good, antiinflammatory activity 
(6) 
R — CHo/ C^Hj-, CH(CH-j)~, 
n-C^Hg, n-C^H^j^, 
Cl2"25 °^ ^^^^^ 
R^ = H, 3-CH2 or 4-OCH2 
A number of biological activities and several other 
uses have been associated with pyrano compounds fused to 
different nitrogen containing heterocycles. This 
prompted several chemists to synthesise and study such 
moieties. Pyrans fused to five membered ring v/ith one 
nitrogen have acquired considerable interest in 
pharmaceutical field. Thus pyranopyrrolidene derivative 
(7) has been used as selective antagonists of 
13 
neuroexcitatory amino acids and pyranoindoles (8) as 
antiallergic agents 
OOH 
R^= 5-tetrazolyl, 5-tetra-
zolylcarbamoyl 
Pyrans, fused to five membered ring with two nitrogens are 
also of great interest. Pyranopyrazoles (9a,9b) have 
15 been reported to possess bactericidal . and of the type 
16 (10) analgesic and antiinflammatory activities. 
(9b) 
(10) 
(9a, 9b,10) R, R^ = Me, Ph, 3-02NCgH^, 4-MeOCgH^ 
Some pyrans fused with six membered heterocyclic system 
having one nitrogen as a part of the ring of the type(11) 
and (12) have been used as amoebicidal and anti-
1 8 
allergic asthma agents, respectively. 
OH Fl, OH 
/::-\^-<::^R9 R^ = H, CO2H, aryl 
J^ R2 = H or Me 
(11) 
R,Rj^,R2 = Me, Et, Bu, Ph, 
C02Et, 0CH2Ph 
Some other derivatives of the type (13) have been used as 
19 brilliant greenish yellow to navy blue dyes 
(13) 
R = H, Halo, alkyl, 
alkoxy, 
n = 1 or 2 
R-,= Ph, thienyl, pyridyl, 
naphthyl etc. 
R2=H, CN, alkoxycarbonyl 
R^=H, CN, carbamoyl etc. 
Pyranopyri-mjfiines, a class of fused cyclic deriva-
tives in which pyran is fused to six membered ring with 
two nitrogens have gained considerable interest due to 
their diverse use in pharmaceutical and dye industries. 
Few pyranopyrim.idine derivatives of the type (14) 
were synthesised and used as analgesic, sedative and 
antiphlogistic agents. 
P 
FT' N 
Me 
H R = H, Me, cyclohexyl 
0 
(14) 
Pyranopyrimidine derivatives like that of (15) have been 
21 
reported as iraportant dyes 
NR 
Me 0 
R = Me, Et 
X = 0, S 
(15) 
Pyranopyrimidines of the type (16) have shov\?n considerable 
22 
herbicidal activity 
\t / \ n 
R, X-
(16) 
^1 = 
^2 = 
n = 
X = 
^1 = 
Z = 
H, halO/ alkyl etc. 
H, Me, OMe, CI, etc, 
1,2; 
CH2, 0 
NHG(Z)NH 
0, S 
Some derivatives of the type (17) are associated with 
. . 23 
anticancer activity 
R^ - Ph, Me-CgH^ 
R2 = H, OMe 
(17) 
Benzopyranopyrimidine dione (18a) and Benzopyranopyrimi-
dinethiones (18b) have been prepared for use in the 
treatment of allergy.(18a) has also been used as antihi-
staminic and serotonin-inhibiting agents ' . 
18a = R=R3^ =H 
R2=H,N02 halogen etc. 
H 
(18a,b) '"2" 
Z =0 
 18b = Z =S , R=R =H 
R^=H, optically 
substituted 
alkyl 
Earlier methods for the synthesis of pyrano[2,3-d]-
Pyrimidines and benzopyranopyrimidines 
A number of methods are available for the synthesis 
of these compounds. Generally starting materials 
employed in these methods are barbituric acids or 2,4,6-
pyrimidinetriones. Most of these reactions may form an 
acyclic intermediate, which often cyclises i.n .situ 
resulting in the formation of pyran ring. 
1. Using barbituric acids 
(i) This method involves the Michael addition of 
barbituric acids (19) to p(, A -unsaturated ketones (A), 
esters (B) or nitriles (C) to give uncyciised adducts, 
which subsequently cyclise to the 
pyrano[2,3-d]pyrimidines ' of the type 20, 21 and 22 
respectively. 
R,CH=CH=C-R2 
(A.) 
(20) 
R,, R- alkyl or aryl 
(22) 
R,,R2/R3 = CN or 
R^-H, R2= aryl, R^^CN 
R = alkyl or aryl 
(ii) This method consists of the reaction between barbi-
turic acid or its derivatives with ^-diketones in 
presence of acid to give pyrano[2,3-d]pyridimines of r.he 
type(23). 
R 
R N 
Rj^COCH^COR 
0 
X' 
( 2 3 ) 
R = alkyl or aryl 
X = acid residue 
R-j^= alkyl or aryl 
(iii) Treatment of barbituric acid or its derivatives 
with acetoacetyl chloride in presence of base gave 
5-acetoacetyl derivatives, which undergo cyclisation in 
7 8 
presence of acid to give pyrano[2,3-d]pyrimidines (24). 
0 
R 
R 
VtH-,CXX3i„ 
J -^^-^ 
R H 
base p^ f\j 
0 
R 
H 
RN. 
'0-
R = alkyl or aryl (24) 
(iv) Barbituric acids on treatment with different 
aliphatic or aromatic aldehydes gave 5-alkylidene or 5-
arylidene derivatives respectively which undergo conden-
10 
sation v;ith acetylenes or esters of unsaturated acids 
follo\>7ed by cyclisation to give pyrano[ 2,3-d]-
pyrimidines ' (25,26). 
R^CHO 
R 
PhHC=CHC02R2 
R PH (25) 
H 
(26) 
R=R2=alkyl, 
R,=alkyl or aryl 
(25) 
OnR-
/NH^ 
^ R = Ph,Ph(Cl),Ph(N02: 
R = C02Et, CN 
(27) 
(v) Reaction of arylidene derivatives of raalonitrile and 
ethyl cyanoacetate with barbituric acid have given pyrano 
pyrimidine diones of type (27) 31 
11 
(vi) This method involves the cyclisation of 5-(3-halo-
propyl) and 5-{3-hydroxybutyl)barbituric acids to give 
3 2a, b 
pyrano[ 2 ,3-d]pyrimidines"" 
respectively. 
of the type (28a) and (28b) 
H 
Qs^N^)^ 
HN 
X = Halogen 
H 
Q x ^ ^ ^ 
HN 
N 
(28a) 
R = H, R, = Cyclohexyl (28b) 
2. Using 4,6-pyrimidinediones 
(i) Pyrimidinediones on treatment with Vilsmeier reagent 
gave compounds of the type (29), which undergo cyclocon-
densation with sodium salt of diethyl malonate to give 
pyrano-[2,3-d]pyrimidines'^-^ (30) . 
12 
POCLy'DNF 
R = H, Me o r Ph 
R y OH 
0 
+ •^^V^^CHizNMe^i 
( 2 9 ) 
Na'^CH{C02Et) 
(30) 
(ii) This method consists of condensation of 4,6-
pyrimidinediones with esters of malonic acids in presence 
34 
of acetic anhydride to give pyrano[2,3-d]pyrimidines 
( 3 1 ) . 
9n 
'° "f-
R = H, CH. (31) 
( i i i ) This method involves the use of modified Pechmann condensation. 
The reaction of pyrimidinediones with ethyl-p~aminocrotonate or with 
open c h a i n i 3 - k e t o e s t e r s i n p r e s e n c e of e x c e s s of ammonium 
13 
acetate as catalyst afforded pyrano[2,3-d]-
pyrimidines ' (32a, 32b). 
C02Et 
CHR^/^^/iOAc R x ^ v ^ \ < P 
H 
R 3 
(32b) 
R=alkyl, aryl; R^=H, Ph; R2^"' ^^2^^' ^3=^lkyl °^ ^^Y^ 
3. Using aminopyran 
(i) Arainopyran (33) used as the starting material, v;as 
prepared by treating appropriate nitrile v;ith dicyano-
methane. This on treatment with acetic anhydride gave 
37 pyrano[ 2 , 3-d Jpyrimidine (34) and v/ith triethoxynethane 
38 
and appropriate amine gave pyrano[2,3-d]pyrimidines of 
the type (35 ) . 
14 
N i t r i l e 
+ 
Dicyanomethane 
Ph^^/-0\/NH. 
^ ' r - ^ ^ ^ -
Synthesis of benzopyranopyrimidine 
Benzopyran-3-carbonitrile (36) when refluxed with 
NH OAc in acetic acid, undergo self condensation 
giving the benzopyranopyrimidine (37) in 13-22% 
yield 
15 
(36) 
R = H, Me, CI, Br, R^ = CN 
(37) 
Benzopyranopyrimidines of type (40) have been 
prepared by the reduction of (39) with NaBH4 24 
H 
NGCH2CONHC02Etp_r^ 
HO ^ 
(38) 
R = R^ = H 
R2 = 7-CH2OH 
( 3 9 ) 
NaBH, 
^ Q 
(40) 
16 
Object of the present work 
It is v/ell known that pyrans and benzopyrans 
individually or in combination with other nitrogen 
containing heterocyclic systems possess significant 
biological properties. Many other cyclic derivatives of 
this type which have gained considerable interest during 
recent years due to their - different uses in 
pharmaceutical field and dye industries, are pyraa<= fused 
to six membered rings with two nitrogens viz. pyrano 
pyrimidines. Pyrimidine itself has exhibited over the 
years remarkable properties which have been usefully put 
into practical application in diverse fields. Keeping 
this in view it was considered of interest to devise a 
convenient route for the synthesis of benzopyrans fused 
with thiobarbiturates. 
Present work 
The present work describes a one step synthesis of 
1, 3-diaryl-5-(1',3'-diaryl-6'-hydroxy-4'-oxo-1',2',3',4'-
tetrahydro-2'-thioxo-5'-pyrimidinyl)-1,2,3,4-tetrahydro-
2-thioxo-4H-[1]-benzopyrano[2,3-d]pyrimidine-4-one 
(44a-f) by the reaction of salicylaldehyde (43) with 
appropriate thiobarbituric acid {42a-f). Different 1,3-
diaryl thiobarbituric acids were prepared by the 
condensation of 1,3-diaryl thiourea (41a-f) v/ith malonic 
17 
acid in presence of acetyl chloride. 
Synthesis of 1,3-diaryl-l,3-dihydro-2-thioxo-2H,5H-
pyriinidine-4 ,6-dione (42a-f) 
1,3-c/iarylthiourea {41a-f) on condensation with 
malonic acid in presence of acetyl chloride gave the 
corresponding 1.3-diaryl-l,3-dihydro-2-thioxo-2H,5H-
pyrimidine-4,6"diones (42a-f). The required 1,3-diaryl-
thioureas (41a-f) were obtained by the .reaction of 
different arylamines with carbon disulphide in absolute 
alcohol. 
s=c 
p 
u/A U acetyl 
n W ^ \ > \ c h l o r i d e 
R-
HO-C' 
0 R-
N ^ 
( 4 1 a - f ) 
R 
( a ) 4-CH. 
( b ) 2-CH. 
( c ) 3-CH. 
( 4 2 a - f ) 
R 
( d ) H 
( e ) 4 - C l 
( f ) 2-OCH. 
18 
Synthesis of 1,3-diaryl-5-(1',3'-diaryl-6'-hydroxy-4'-
oxo-1',2•,3•,4•-tetrahydro-2'-thioxo-5'-pyrimidinyl)-
l,2,3,4-t3trahydro-.2-thioxo-4H-lll-benzopyrano[2,3-d] 
pyrimidine-4-one (44a-f) 
In a, typical case, l,3-di(4-methylphenyl)thiobar-
bituric acid (42a) on reaction with salicylaldehyde (43) 
in presence of methanol with fev; drops of 30% HCl gave a 
solid product. Its H NMR shov/ed beside other usual 
signals a singlet at S 4.5 for one proton (exchangeable 
with D_0) assigned to OH at position C-6' and a singlet 
observed at 5 5.4 for one proton v/as assigned to proton 
at position C-5. The I.R. spectrum showed OH function 
(3450 cm" ) and >C=0 functions (1720 cm"-^ , 1695 cm~^ ) . 
On the basis of spectral data and elemental analysis the 
structure was formulated as 1,3-di(4-methylphenyl)-5-
[1',3'-dK4-methylphenyl)-6'-hydroxy-4'-oxo-1' , 2 ' , 3' ,4'-
tetrahydro-2'-thioxo-5'-pyrimidinyl]-l,2,3,4-tetrahydro-
2-thioxo-4H-[1]-benzopyrano[2,3-d]pyrimidine-4-one (44a) . 
Similarly compounds (44b-f) were prepared by the 
reaction of appropriate thiobarbiturate (42b-f) v;ith 
salicylaldehyde (43). 
19 
( 4 2 a - f ) 
+ 
(43) 
MeOH HCL 
( 4 4 a - f ) 
R 
( a ) 4-CH. 
( b ) 2-CH. 
( c ) 3-CH. 
R 
( d ) H 
( e ) 4 - C l 
( f ) 2-OCH. 
20 
Mechanism 
R^./^^ 
0^ 
HO^^^x 
R R 
( 4 4 ) 
21 
Experimental 
Synthesis of 1,3-diaryl thiourea ' (41a-f) 
41 1,3-Di(4-methylphenyl)thiourea (41a j 
4-Methylaniline (24.4 g, 23 ml, 0.22 mol), carbon 
disulphide (25 g, 20 ml, 0.33 mol) and absolute ethano] 
(25 g, 31.75 ml) placed in a round bottomed flask, were 
refluxed on a steam bath for 8 hours. The solid thus 
obtained v;as filtered and v;ashed with excess of dilute 
hydrochloric acid (1:10) and ethanol to remove any un-
reacted aniline, filtered at pump and dried. The crude 
thiourea was then crystallised from ethanol as white 
shining crystals of 41a, 32g, m.p. 174-75°C (lit. 
m.p. 176-77°). 
41 l,3-Di-(2-methylphenyl) thiourea (41b) 
2-Methylaniline (24.4 g) on condensation with 
carbon disulphide (25 g) in absolute ethanol gave 41b as 
41 
white crystalline solid, 30 g, m.p. 161-62° (lit. , 
m.p. 161-62°). 
41 1.3-Di-(3-methylphenyl)thiourea (41c) 
3-Methylaniline (24.4 g) on condensation with 
carbon disulphide (25 g) in absolute ethanol gave 41c as 
22 
41 
v/hite c r y s t a l l i n e s o l i d 30 g, m.p. 110-11 ( l i t . m.p, 
111-12°) . 
40 1,3-Diphenylthiourea (41d) 
Aniline (20 g) on condensation with carbon disul-
phide (25 g) in absolute ethanol gave 41d as white cry-
40 
stalline solid, 27 g, m.p. 153-54°C (lit. m.p. 
154-55°C). 
41 1,3-Di(4-chlorophenyl)thiourea (41e) 
4-.Chloroaniline (25.6 g) on condensation with 
carbon disulphide (25.0 g) in absolute ethanol gave 
(41e) as white crystalline solid, 25.5 g, m.p. 176-77°C 
dit.'^-^ m.p. 176-77°). 
42 1,3-Di(2-methoxyphenyl)thiourea (41f) 
2-Methoxyaniline (24.0 g) on condensation v/ith carbon 
disulphide (25 g) in absolute ethanol gave (41f) as 
v/hite shining crystals, yield 22 g, m.p. 175-76°C 
(lit.^^ m.p. 176-77°). 
Synthesis of 1,3-diaryl thiobarbituric acids (42a-f) 
1,3-Di(4-methylphenyl)-1,3-dihydro-2-thioxo-2H,5H-pyrimi-
42 dine-2,4-dione (42a) 
1,3-Di(4-methylphenyl)thiourea, 41a (2.56 g, 0.01 
23 
mol), malonic acid (1.1 g, 0.01 mol) and acetyl chloride 
(10 ml) were refluxed on a steam bath for 20 minutes. 
The reactii-a mixture on cooling and treatment with 
crushed ice solidified which was filtered, dried aad 
recrystallised from acetic acid, as yellow crystalline 
solid 42a, 2.8 g (86%), m.p. 231-32°C (lit.*^ m.p. 
233-34°). 
1,3-Di-(2-methylphenyl)-1,3-dihydro-2-thioxo-2H,5H-pyri-
midine-4,6-dione (42b) 
1,3-Di-(2-methylphenyl)thiourea 41b (2.56 g) on 
condensation with malonic acid (1.10 g) in presence of 
acetyl chloride gave 42b as yellow crystalline solid, 
3.04 g, m.p. ISO-gi'-C (lit.^^ m.p. 191-92°). 
1,3-Di-(3-methylphenyl)-1,3-dihydro-2-thioxo-2H,5H-pyri-
42 
midine-4,6~dione (42c) 
1,3-(Dxphenyl)-hiourea 41c (2.56 g) on condensa-
tion with malonic acid (1.0 g) in presence of acetyl 
chloride gave 42c as yellow crystalline solid, 3.1 g, 
m.p. 261-62°C (lit.'*^ m.p. 262-63°). 
1,3-Diphenyl-l,3-dihydro-2-thioxo-2H,5H-pyrimidine-4,6-
dione^^ (42d) 
1,3-Diphenyl thiourea, 41d (2.28 g) with malonic 
24 
ac id (1.10 g) and a c e t y l c h l o r i d e (10 ml) gave 41d as 
yellov/ crystals, 2.07 g, m.p. 2 .^5'-46°C ( l i t . m.p. 245-46°). 
1,3-Di-(4-chlorophenyl)-1,3-dihydro-2-thioxo-2H,5H-pyri-
42 
niidine-4,6-dione (42e) 
1,3-Di-{4-chlorophenyl)thiourea, 41e (2.98 g) on 
condensation with malonic acid (1.1 g) in presence of 
acetyl chloride gave 42e as yellow crystalline solid, 
2.6 g, m.p. 203-04°C (lit.'*^, m.p. 203-04°C ) . 
1,3-Di-(2-methoxyphenyl)-1,3-dihydro-2-thioxo-2H,5H-pyri 
42 
midine-4,6-dione (42f) 
l,3-Di-(4-chlorophenyl)thiourea, 41f (2.88 g) on 
condensation with malonic acid (1.10 g, 0.01 mol) in 
presence of acetyl chloride gave 42f as yellow 
42 
crystalline solid, 2.3 g, m.p. 203~04°C (lit. m.p. 
203-04°C). 
Synthesis of [1] benzopyrano pyrimidines (44a-f) 
1,3-Di(4-methylphenyl)-5-[1',3'-di(4-methylphenyl)-6'-
hydroxy-4'-oxo-1",2•,3',4•-tetrahydro-2'-thioxo-5'-
pyrimidinyl)-1,2,3,4-tetrahydro-2-thioxo-4H-[1]-benzopyr 
ano[2,3-d]-pyrimidine-4-one (44a) 
A solution of l,3-di(4-methylphenyl)-thiobarbi-
^5 
turic .acid (42a, 3.24g, 0.01 mol) and salicylaldehyde 
(43, 0.61g, 0.005 mol) in methanol in the presence of 
hydrochl'^ric acid (2-3 drops) was refluxed for 30-J 5 
min. The reaction mixture was coded. The solid thus 
separated was filtered, dried and crystallised from 
chloroform-methanol as yellow crystals of 44a (5.9g, 
yield 80%) m.p. 230-232°C. 
I.R. •» Nujol ^^-1 . 3450 1720, 1695, 1685, 1640, 
max 
1580, 1500, 1340, 1260, 1200, 
1160, 1100, 1010, 760 
H-NMR (CDCl^) <S : 2.5 (12H, S, 4xCH2) , 4.5 (IH, S, 
OH, D2O exchangeable), 5.40 (IH, 
S, 5-H) 6.8-7.8 (20H, m, Ar-H). 
MS (m/z) : M"^  734; 408 : 322; 260; 157; 105. 
Analysis : Calculated for C.-.H-, .N .0 .S„ : C, 
•^  43 34 4 4 2 
70.2; H, 4.6; N, 7.6. Found : C, 
70.3. H, 4.5; N, 7.9. 
26 
1,3-Di(2-methylphenyl)-5-[1'-3'-di(2-methylphenyl)-6'-
hydroxy-4'-oxo-1',2',3•,4'-tetrahydro-2•-thioxo-5'-
pyrimidinyl]-1,2,3,4-tetrahydro-2-thioxo-4H-[1]-bensopyr 
ano[2,3-d]-pyrimidine-4-one (44b) 
1,3-Di(2-methylphenyl)-thiobarbituric acid (42b, 
3.24g, 0.01 mol) and salicylaldehyde (43, 0.61g, 0.005 
mol) were condensed following the same procedure as 
given above to give a solid, v/hich was recrystallised 
from chloroform-methanol as yellow crystals of 44b 
(5.5g, yield 75%) m.p. 241-42°C. 
I.R. -^ Nujol j^„-l . 3450, 1720, 1695, 1680, 1640, 
max 
1585, 1495, 1340, 1260, 1195, 
1160, 1100, 760. 
••-H-NMR (CDCI3) & : 2.5 (12H, S, 4XCH3) , 4.5 (IH, S, 
OH, D2O exchangeable), 5.4 (IH, S, 
5-H) 6.8-7.8 (20H, m, Ar-H). 
Analysis : Calculated for ^^2^34^4^4^2 ' ^' 
70.2; H, 4.6; N, 7.6. Found : C, 
70.1; H, 4.5; N, 7.5%. 
27 
1,3-Di (3--inethylphenyl )-5-[ r, 3' -di (3-methylphenyl) -6-
hydroxy-4'-oxo-1',2',3',4-tetrahydro-2'-thioxo-5'-
pyrimidny1]-1,2,3,4-tetrahydro-2-thioxo-4H-[1]-benzo-
pyrano[2,3-dIpyrimidine-4-one (44c) 
1,3-Di(3-methylphenyl)-thiobarbituric acid (42c, 
3.24g, 0.01 mol) and salicylaldehyde (43, 0.61g, 0.005 
mol) were condensed by following the same procedure as 
described in above case to give a solid, which was 
recrystalised from chloroform-methanol, as yellow 
crystals of 44c (6.0g, yield 82%) m.p. 282-285°C. 
I.R. -^  Nujol ^^-l . 3455 1715, 1695, 1635, 1580, 
max 
1495, 1340, 1265, 1200, 1160, 
1010, 760. 
•'•H-NMR (CDCl^) S : 2.5 (12H, S, 4XCH2), 4.5 (IH, S, 
OH, D2O exhcnageable), 5.35 (IH, 
S, 5-H), 6,8-7.6 (20H, m, Ar-H). 
Analysis : Calculated for C.~,E~,.N.O.S^ : C, 
43 34 4 4 2 
70.2; H, 4.6; N, 7.6. Found : C, 
7 0.3; H, 4.5; N, 7.4%. 
28 
1, 3-Diphenyl-5- [ l', 3-diphenyl-6' -hydroxy-4-oxo-1 •, 2', 3', 
4•-tetrahydro-2'-thioxo-5•-pyrimidinyl]-1,2,3,4-tetrahy-
dro-2-thioxo-4H-[1]-benzopyrano[2,3-d]-pyrimidine-4-one 
(44d) 
1,3-Diphenyl-thiobarbituric acid {42d, 2.96g, 0.01 
mol) and salicylaldehyde (43, 0.61g, 0.005 mol) were 
condensed by following the same procedure as described 
in above cases to give yellov\? solid which was 
recrystallised fr-om chloroform methanol to give yellow 
crystals of 44d (5.7g, yield 85%) m.p. 264-266°C. 
I.R.T) '^ ^^ ol ^^-1 . 34QQ^ 1715, 1680, 1645, 1505, 
max 
1335, 1260, 1010, 740. 
H-NMR (CDCl^) -S : 4.5 (IH, S, OH, D^O exchangeable), 
5.4 (IH, S, 5-H), 6.9-7.8 (24H, m, 
Ar-H). 
Analysis : Calculated for C2qH2gN.O^S2 : C, 
69.0% ; H, 3.8; N, 8.2. Found : 
C, 68.8; H, 3.9; N, 9.1%. 
29 
1,3-Di(4-chlorophenyl)-5-[1',3'-di(4-chlorophenyl)-6'-
hydroxy-4'-oxo-1•,2',3',4'-tetrahydro-2'-thioxo-5'-
pyrimidiny1]-1,2,3,4,-tetrahydro-2-thioxo-4H-[1]-benzopy 
rano[ 2,3-d]pyi:imidine-4-or.e (44 e) 
1,3-Di{4-chlorophenyl)-thiobarbituric acid {42e, 
3.64g, 0.01 mol) and salichlaldehyde (43, 0.61g, 0.005 
mol) were refluxed in methanol in presence of 
hydrochloric acid for 40 min. The reaction mixture 
was worked up as in above case to give a solid, which 
was recrystalised from chloroform-methanol as yellow-
solid of 44e (6.5g, yield 80%) m.p. 274-75°C. 
I.R. ^  !!^ ?.°^  cm •"• : 3445, 1720, 1680, 1635, 1585, 
1490, 1345, 1265, 1200, 1165, 760. 
max 
^H-NMR (CDCl^) 6 : 4.5 (IH, S, OH, D2O exchangeable) 
5.45 (IH, S, 5-H), 6.8-7.8 (20H, 
m, Ar-H). 
MS (m/z) : M"^  814; 451, 363, 308, 179, 169, 
111. 
Analysis : Calculated for COQH^^CI.N O.S„ : 
C, 57.4; H, 2.7; N, 6.8%. Found, 
C, 57.3%; H, 2.5; N, 6.9%. 
30 
1,3-Di(2-methoxyphenyl)-5-(1',3'-di(2-methoxyphenyl)-6'-
hydroxy-4 ' -oxo-1' , 2 ' , 3 ' , 4 ' -tetrahydro '-2 ' -thioxo-5 • -
pyriinidinyl-1 #2,3, 4-te trahydro-2-thioxo-4H-[ 1 ] -benzo-
pyrano[2,3-d]-pyrimidine-4-one (44 f) 
1,3-Di(2-methoxyphenyl)-thiobarbituric acid (42f, 
3.56g, O.Ol' mol) and salicylaldehyde (43, 0.61g, 0.005 
mol) were condensed by following the same procedure as 
described above to give a yellow solid which was 
recrystallised from chloroform-methanol as 44f (6.4'Sg; 
yield 81%), m.p. 238-239°C. 
I.R. ^  Nujol ^^ 1 . 3450, 1700, 1680, 1640, 1500, 
1340, 1260, 1160, 1020, 740. 
max 
•"•H-NMR (CDCl^) S : 3.9 (12H, S, 4XOCH3) , ^'^ ^•^^' ^' 
OH, D2O exchangeable),5.45(IH, 
S,5-H),6.9-7.7 f20H,m,Ar-H). 
Analysis : Calcualted for C^2H34N.OgS2 : C, 
64.6; H, 4.2; N, 7.0. Found : C, 
64.3; H, 4.3; N, 7.2%. 
31 
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CHAPTER II 
Synthesis of l,3-diaryl-l,3-dihydro-S-(?-substituted 
t:hiazol-4-y 1) -2-thioxo-2H, 5H-py r imidine-4 , 6-diones 
Introduction 
It has already been described (Chapter - I) that 
pyrimidines are associated with a wide range of 
physiological properties. Similarly thiazoles (1) have 
also been knov/n for their biological & therapeutic 
properties. 
4 
5 
;N 5 
•S' !)2 
Th 
(1) 
iazole moiety is an integral part of vitamin B, 
1 2 
(thiamine chloride hydrochloride) (2) and penicillins 
(3). This prompted the chemists to develop new routes 
for the synthesis of different thiaz'^le derivatives in 
order to assess the structure - activity relationships. 
+ -
'3' ^ ^ s _ 
-t: 
I-: 2V 
^^ 6 
•S' ^^ 4-^ "CH ^
 
HOOC- X: 
S^' ^NHOOR 
3) 
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The literature available on thiazoles is too volu-
minous to be discussed here. Here only a few general 
methods for the synthesis of thiazoles and their 
physiological properties have been discussed. 
Since nineteenth century, large number of 
thiazoles have been synthesised which are known to be 
associated with diverse activities. 
The therapeutic effect of sulphonamides is well 
understood. In normal therapei^tic conditions, they do 
not kill bacteria but they inhibit the growth and 
multiplication of the infectious organism and thus allow 
the host to eradicate the infection by normal defence 
mechanism. 
3 
Among the various sulphonamides kno'.^ n, sulpha-
thiazole (4) is the drug of choice in the treatment of 
streptococcal, staphylococcal, pneumococcal and 
gonococcal infections. It has also been found to be 
effective in combating infections of Schiqella 
3 
dysenteriae and Myobacterium tubaculosis. 
Sulphathiazole (4) is advised as a hair lotion additive 
for defatt-jng the hair and reducing formation of 
dandruft . Compound (5) is another drug of interest 
which gives better results than sulphathiazole in 
treating baciljary dysentary . 
38 
;N 
AN HSQ P \ — 
// V H 
-? 
(4) 
Aoni 
(5) 
2-(p-Acetainidosulphonamide)-4-methyl thiazol -5-
yl-mercaptoacetic acid (6) was found to possess 
antioxidation effect and also antibiotic power 
comparable to that of common sulphonaraide . 
H3C 
R = SCH2COOH (6) 
Aminophenazole (7) showed some CNS stimulant activity , 
more specifically the compound antagonises the 
depression caused by overdoses of barbiturates and 
narcotics. 
S^^h'. 
(7) 
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2-Ainino-4-phenyl-5-sulphonamide thiazoles (8) has 
been found to be effective against various strains of 
bacteria e.g. Bacillus subtillis, B. cereus, B,myceides 
E. coli and Salmonella typhosa. 
R = SO2NHCH2COOH 
(8) 
Thiazoles containing hydroquinone (9) and 
p-benzoquinone moiety (10) at 4-po3ition are also 
associated with anti-bacterial activity . 
,x^:^X)H 
HO-^^^ n 
^ S - - ^ T 4 H R 
(9 
R = 
^ ^ 
^S>^HR 
(10) 
H, C,Ht-. p-ClC^H., p-BrC,H , , p-NH^C,H. 6 5 6 4 ' - b 'i Z b % 
Several hydrazones prepared from 2-hydrazino-6-
substitutGd benzothiazoles (11) and 2-alkyl or 
arylan-no-6-methylben2othiazoles (12) v/ere found to be 
antituoerculosis agents 9-10 
40 
(11) 
NHR 
(12) 
P, = NHN=CH-Ph R = alkyl or aryl 
2-Aminothiazole condensed with coumarin ring (13) 
and thiazolyl aminobenzoquinones of the type (14) are 
• ^ -, -^ -^  11,12 
also associated with antitubercular activity 
Q 
Ri R- (14) 
Chromonyl thiazoles of the type (15) are known to 
exhibit CNS depressant, hypotensive and hypothermic 
13 
activity . Recently thiazolylcouitiarins (16 & 17) have 
been synthesised and found to possess antiinflammatory 
14 1 f^  properties ' . 
CI 
R XJ^TV^, 
(15) 
R = H, CH, 
RT= NH 
2' N"^6"5' C6«5 
p-ClCgH^ 
(16) 
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(17) 
R, R-|^  = CI, H; CH^, H; OCH3, H; 
CI, 4-Cl; CI, 5-Cl; CH^, 4-Cl 
Mercapto thiazoles are ssociated -with multifarious 
activities. 2-Mercapto-5-(p-hydroxyethy1)-4-methyIthia-
zole (18) has been found to possess anthelmintic 
activity 
type (19) are also associated with similar activity 
16 The isothiocyanatophenyl thiazole of the 
17 
H. 
R 
rN 
>:> 
(18) 
^H ol 
R = CH2CH2OH 
S-^R. 
(19) 
R = H, CI, NCS etc. 
Ri H, NCS 
R2 = SCH^, SCH(CH,) 
3'2 
R3 = H, CH3 
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2-Substituted mercaptothiazoles (20) and (21) 
have been found to be potent fungicide. 
nx- t1 
o 
(20) (21) 
R = C^Hg, CH2COCH3,COCgH5 R = alkyl 
2-Methylmercapto-4,5-bis-(4-methoxyphenyl)thiazole 
20 (22) is reported to be useful as antirheumatic 
H3C0 
/, 
-N 
^3 (22) 
SC1^3 
Aminoalcohol derivatives of the type (23) have 
been found to be p-adrenergic receptor blocking 
^ 21 agents 
RCO-
-t^  X' :N 
^S^SCHpCHCHoN. ' 
'2^  n £. 
(23) 
R = alkyl, OH, alkoxy, NH, 
R^/ R2 "" "' ai^^yi; X = 0, s 
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2-Arylmercaptothiazoles (24) are associated with 
antiphlogistic analgesic and anti-inflammatory 
activity 22 
;N 
^ ^ S 
R 
' / \ 
R 2 
(24) 
-^ 
R = H, OCH3, Halogen; R ^ 
R = et CH^, C1,'C00H, carboxyalkyl 
2-Thiazolyl sulphoxide (25) and (26) have been 
found to be CNS depressant and useful as minor 
23 tranquilizers, sedatives and hypnotxcs 
:N 
Ph-^s-^-^soc^ pir^s-^socHj 
(25) (26) 
2-Mercaptoacetic acid of the type (27) exhibits 
analgesic, antiinflammatory and 
24 
antipyretic 
s 
activities ". 5-Nit-ro-? 9'_4-K-;^K- i^_ • 
J wicro ^,^ -thiobisthrazole (28) i 
reported to be associated with antibacterial activity^^ 
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R-
'^-
( 2 7 ) 
R 
:N Nr ^ 
2 ( 2 8 ) 
R 
S-^R 
R=CH,'Ph, R =H, C l ; R^=CH^COOH R^  R,= H, Me, Bt. 
T h i a z o l o ( 4 , 5 - b ) p y r i m i d i n e s (29) and ( 2 - t h i a z o l y l -
t h i o ) - a l k a n o a t e s (30) a r e a l s o p h a r m a c e u t i c a l l y 
i m p o r t a n t 26 ,27 
S^'SR 
^"^ N 
fT^S"^(CH)pOOR 
( 2 9 ) 
R = sub alkyl, alkenyl 
2 6 5 
(30) 
R =^  H, alkyl 
Rj^,R2=H, Halo,-CN, -NH„ 
(un)substituted alkyl, 
aryl, acyl, n=2-10 
Cationic methine dye e.g. compound (3.1) is used to 
obtain positive coloured images with 
• -, 28 
m a t e r i a l 
c o p y i n g 
H 
(sh^r "^1 
CH^CLQ;^ 
:N 
\ SCH 3 
( 3 1 ) 
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Methods of synthesis of thiazoles 
The general methods for the synthesis of thiazoles 
are as follows. 
(I) Hantzsch thiazole synthesis 
This versatile synthetic procedure is of great 
29 
synthetic utility for the preparation of thiazoles 
It involves the condensation of <<-halocarbonyl compounds 
(32) with thioamides (33) to give thiazoles (34). 
thioacetamide (33, R„=CHT) gives 2-methyl thiazoles, a 
useful extension involves the use of ammonium dithio-
carbamate {33, Rp=S NH , ) to' give 2-mercapto thiazoles. 
NHp o 
* ^>^—t,u .^ 
(3^) (34) 
•'S 4 
:-o 
:HX 
( 3 2 ) 
M e c h a n i s m 
K C~~N 
(34) 
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(II) Reaction with a metal thiocyanate 
Some metal thiocyanates condense with 
(?(rhaloketones (32) to yield oc-thiocyanatoketones (35) 
which cyclise to give a variety of 2-substituted 
thiazoles in presence of different reagents . For 
instance, 2-hydroxythiazoles (36) are produced in 
presence of mineral acids v\7hereas 2-chlorothiazoles (37) 
are formed in presence of anhydrous hydrogen chloride or 
phosphorous pentachloride. 2-Mercaptothiazoles (38) and 
2-substituted aminothiazoles (39) "can also be obtained 
by treating o<-thiocyanatoketones (35) with hydrogen 
sulphide and amines respectively. 
R 
•N 
(36) 
R-<:=0 M^'^^S^-^CN 
R | K : H - X 
(32) 
-JN 1/ 
(38) 
R-
R-Q^J 
R-^HSCN 
(35) 
R2NH2 
(39) 
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(III) Condensation involving o^-aminonitriles 
Treatment of o(,-aminonitriles (40) with carbon dis-
ulphide, salts and esters of dithioformic acid, 
carbonoxy sulphide and alkyl or aryl isothiocyanates 
41 42 
afforded ' 5-amino-2-mercaptothiazoles (41), 4-alkyl 
(or aryl)-5-aminothiazoles (42), 5-amino-2-hydroxy-
thiazoles (43) and 2-N-substituted amino-5-amino-
thiazoles (44), respectively. 
R 
R~ 
4 2_ 
O" S^H 
( 4 1 ) 
-N 
Rn 
R-CH~NH 
CN 
( 4 0 ) 
2' 
s = 
(43) 
•SH 
H-NH 
N 6 -
1 
R, 
o 
N * ' 
R \ _ 
-N 
( 4 2 ) 
^-^-^- (40) -%i i£S ^ 
R-CH-NH ? 
CN C - N H R 
R 
V 
^ 
\ 
H 
-N 
-NHR 
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(IV) Condensation involving o^-aminoamides 
A convenient two step synthesis of thiazoles 
involves the condensation of oc-aminoamides- (45) with 
carbon disulphide in presence of a base to give the salt 
of the corresponding dithiocarbamic acid (46), which 
undergoes acid catalysed cyclisation in the second step 
to yield 5-hydroxy-2-mercaptothiazole (47). 
(45) (46) 
HO^S 
(47) 
(V) Condensation involving 2-bromoalkylainines 
2-Substituted thiazoline derivatives can be 
obtained by condensation of different reagents with 2-
bromoalkylamines (48). Thus, 2-alkyl (or aryl)-2-
thiazolines^ (49), 2-amino-2-thiazolines (50) and 2-
mercapto-2-thiazolines'^^-51 (51) are obtained from 
thioamides, potassium thiocyanate and carbon disulphide, 
respectively. 
49 
H 
R-CH-Br 
' (48) 
'^^k C X ^ 
s-c=s 
(49) 
V-
KSCN 
N 
H 
>^ H. 
'Z 
(50) 
H R-^  
R|^  
^ M 
i^S-^SH 
(51) 
(VI) Synthesis from M-acylaminocarbonyl compounds 
A useful synthetic procedure involves the cycli-
sation of cK-acylaminocarbonyl compounds (52) with 
52,53 
phosphorous pentasulphide 
disubstituted thiazoles(53). 
to give 2,5-
(52) 
2^^ 5 ^ ^"Trr—i^ 
Rp^S-^R, 
(53) 
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(VII) Syn thes i s from o^-mercaptocarbonyl compounds 
<x-Mercapto a c i d s or t h e i r e s t e r s on condensat ion 
54-59 
with anils yield 4-oxothiazolidines" ( 5 4 ) . 
HSChkCOOR 4- C^H,fh-HC^^^-^ N-^^5 
R = H, a l k y l (34) 
(VII I ) Syn thes i s from 2-mercaptoalkyl cimines 
Condensation of 2.-mercaptoalkyl amines (55) v/ith 
e s t e r s or ke tones p rov ides 2 - t h i a z o l i n e s (56) and 
t h i a z o l i d i n e s (57 ) , r e s p e c t i v e l y 
R R 
m-i-c-SH 
CH^COOC^H^ 
R R 
( 5 5 ) J?-, COR, 
(56) 
R 
R/ NH 
R 
( 5 7 ) 
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Objects of the present work 
The association of pyrimidines with a number of 
physiological activities has already been discussed (see 
Chapter - 1). This has resulted in the synthesis of 
some new derivatives during the past few decades in 
order to establish structure-activity relationships as 
well as in search of more potent compounds. On the 
other hand, thiazols are known to exhibit significant 
biological properties as discussed already. 
The biological importance of pyrimidines and 
thiazoles, individually or in combination, prompted to 
construct molecules possessing both these units. 
Keeping this in view, a convenient synthesis of such 
compounds has been devised. 
Present work 
The present work describes a facile synthesis of 
1,J-diaryl-1,3-dihydro-2-thioxo-5-(2-mercaptothiazol -4-
yl)-2H,5H-pyrimidine-4,6-diones (61a-f) and 
1,3-diaryl-l/3-dihydro-2-thioxo-5-(2-methylthiazol-4-yl) 
-2H,5H-pyrimidine-4,6-diones (62a-f). it involves the 
reaction of different 1,3-diaryl-l,3-dihydro-2-thioxo-
2H,5H-pyrimidine-4,6-diones, commonly known as 
1,3-diaryl thiobarbituric acids (59a-f) with 
52 
chloroacetyl chloride in presence of triethylamine to 
yield the corresponding 5-chloroacetylpyrimidinediones 
(60a-f) as intermediates. These on further condensation 
with ammonium dithiocarbamate or thioacetamide in 
absolute ethanol afforded the required (61a-f) and 
62{a-f) respectively. 
Synthesis of l-phenyl-3-aryl-l,3-dihydro-2-thioxo-2H,5H-
pyrimidine-4,6-diones (59a-f) 
l-Phenyl-3-arylthiourea (58a-f) on combination 
with malonic acid in presence of acetyl chloride gave the 
corresponding l-phenyl-3-aryl-l,3-dihydro-2-thioxo-2H, 
5H-pyrimidine-4,6-diones (59a-f). 
-R 
S=C, + 
HO-
r 1^  
acetyl ^ 
chloride Q 
-R 
-> 
^ 
0 
(59a-f) (58a-f) 
The required l-phenyl-3-arylthioureas (58a-f) were 
obtained by the reaction of phenyl isothiocyanate with 
different arylamines. 
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Synthesis of l-phenyl-3-aryl-l,3-dihydro-2-thioxo-5-
chloroacetyl-2H,5H-pyrimidine-4,6-diones (60a-f) 
In a typical caser the reaction of l-phenyl-3-(2-
methylphenyl)-1/3-dihydro-2-thioxo-2H,5H-pyrimidine-4,6-
dione (59a) with chloroacetyl chloride in dry benzene in 
the presence of triethylamine afforded a crystalline 
solid. Its elemental analysis showed the presence of 
chlorine, further the positive DNP test indicated the 
introduction of chloroacetyl group to the moiety. In 
its H NMR spectrum,besides other signals, a singlet for 
two protons was observed at f4.90. This was attributed 
to the -CHp-protons of chloroacetyl moiety. On the 
basis of the spectral data and elemental analysis, it 
was assigned the structure as 
l-phenyl-3-(2-methylphenyl)-1,3-dihydro-2-thioxo-5-
chloroacetyl-2H, 5H-?yrimidine- 4 , 6-dione (60a). 
Similarly the reaction of other l-phCinyl-3-
substituted phenyl thiobarbituric acids (59b-f) with 
chloroacetyl chloride gave the corresponding 
chloroacetyl derivatives (60b-f). 
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CICH^COCl 
( 5 9 a - f ) ( 6 0 a - f ) 
R R 
( a ) R = 2-CH3 ( d ) R = 3 - C l 
( b ) R = 3-CH3 ( e ) R = 4 - C l 
(c) R = 4-CH3 (f) R = '^-B^ 
Synthesis of l-phenyl-3-aryl-l,3-dihydro-5-(2-mercapto-
thiazol -4-yl)-2-thioxo-2H,5H-pyrimidine-4,6-diones 
(61a-f) 
As a typical case, the 5-chloroacetyl derivative 
(60a) was condensed with ammonium dithiocarbamate in 
absolute ethanol to give a solid product which gave a 
negative DNP test. Its elemental analysis indicated the 
absence of chlorine. The H-NMR spectra shovi7ed a D2O 
exchangeable singlet at S 4.8 for one proton, attributed 
to the mercapto group of the thiazole ring. A multiplet 
at S 7.0-7.9 for eleven protons v/as assigned to 5'-H and 
5-H merged with nine aromatic protons. A singlet at 
S 2.15 integrated for three protons was assigned to 
methyl group. In IR ^ max°''" ^4 50 cm""'' the presence of 
-SH was indicated. The presence of SH group was further 
confirmed by methylation with methyliodide in presence 
of potassium carbonate in acetone. The H-NMR spectrum 
of the methylated product showed 3H singlet at ^^3.4, 
55 
assigned to S-CH^ group. On the basis of the above 
spectral data, derivatisation and elemental analysis, it 
was formulated as l-phenyl-3-(2-methylphenyl)-l,3-
dihydro-5-(2-raercaptothiazol-4-yl)-2-thioxor2n, 5H-
pyrimidine-4,6-dione (61a). 
Similarly the reaction of other chloroacetyl 
derivatives (60b-f) on condensation with ammonium 
dithiocarbamate gave the corresponding 
l-phenyl-3-aryl-l,3-dihydro-5-(2-mercaptothiazol-4-yl)-
2-thioxo-2H,5H-pyrimidine-4,6-diones (61b-f). 
(60a-f) 
+ 
J ^-. 
H^N^-6NH4 
(61a-f) 
(a) 2-CH. 
(b) 3-CH. 
(c) 4-CH, 
(d) 3-Cl 
(e) 4-Cl 
(f) 4-Br 
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Synthesis of l-phenyl-3-aryl-l,3-dihydro-5-(2-inethyl-
thiazol-4-yl)-2-thioxo-2H,5H-pyrimidine-4,6-diones 
(62a-f) 
As a typical case, the condensation of 
5-chloroacetyl derivative (60a) with thioacetamide in 
absolute ethanol gave a solid which did not respond to 
DNP test. The H NMR spectral data showed a singlet at 
S 2.8 for three protons, assigned to 2'-C}i^ of the 
thiazole ring. While the 5-H singlet at S 8.4 was 
clearly descernible , the resonance of the 5-H overlaped 
with the aromatic multiplet at S 7.15-7.95. On the basis 
of above spectral data and elemental analysis, it was 
assigned the structure, l-phenyl-3-(2-methylphenyl)-1,3-
dihydro-5-(2-methylthiazol-4-yl)-2-thioxo-2H,5H-pyrimidine 
4,6-dione (62a). 
The compounds (62b-f) were prepared in a similar 
manner by the condensation of the corresponding 
5-chloroacetyl derivative (60b-f) with thioacetamide. 
( 6 0 a - f ) 
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-f-
I 
^v 
s 
II 
H N-C-CH 
7] 
n 
^^S/^H 3 
( 6 2 a - f ) 
(a) 
( b ) 
( c ) 
( d ) 
( e ) 
( f ) 
R 
2-CH 
3-CH 
4-CH 
3 - C l 
4 - C l 
4 - B r 
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EXPERIMENTAL 
Synthesis of 1,3-diarylthioureas (58a-f) 
63 l-Phenyl-3-(2-raethylphenyl)thiourea (58a) 
General Procedure 
2-Methylaniline (1.0 7 ml, 0.01 mol) and phenyl 
isotbiocyanate (1.35 ml, 0.01 mo] ) were dissolved in 
ethanol (25 ml), and heated for 20 minutes on a steam 
bath. The contents soldified on cooling. The crude 
thiourea v/as then crystallised from alcohol to give 58a 
as white solid 2.1g yield 86%, m.p. 140-41° (lit m.p. 
141°) . 
fi 3 1-Pheny1-3-(3-methyIpheny1)thiourea (58b) 
3-Methylaniline (1.07 ml) on condensation \;ith 
phenylisothiocyanate (1.35 ml) in ethanol gave 58b as 
v/hite crystalline solid (2.0 g), m.p. 135-36° (lit m.p. 
135°) . 
fi "I 
l-Phenyl-3-(4-methylphenyl)thiourea (58c) 
4-Methylaniline (1.07 ml) on condensation with 
phenylisothiocyanate (1.35 ml) in ethanol gave 58c as 
white crystalline solid (2.1 g), m.p. 138-39° (lit^^ 
m.p. 138°), 
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1-Phenyl-3-(3-chlorophenyl)thiourea^^(58d) 
3-Chloroaniline (1.2 ml) on condensation with 
phenylisothiocyanat3 (1.3 ml) in ethanol gave 58d ac 
white crystalline solid (2.5 g), ra.p. 142-43° (lit m.p, 
142°) . 
l-Phenyl-3-(4-chlorophenyl)thiourea (58e) 
4-Chloroaniline (].2 ml) on condensation with 
phenylisothiocyanate (1.3 ml) in ethanol gave 58e as 
white crystalline solid (2.4 g), m.p. 147-48° 
(lit.^^m.p. 147°). 
6 ^  l-Phenyl-3-(4-bromophenyl)thiourea (58f) 
4-Bromoaniline (1.7 ml) on condensation with 
phenylisothiocyanate (1.3 ml) in ethanol gave 58f as 
white crystalline solid (2.8 g), m.p. 153-54° 
(lit.^^m.p. 153°). 
l-Phenyl-3-(2-methylphenyl)-l,3-dihydro-2-thioxo-2H,5H-
64 pyrimidine-4,6-dione (59a) 
General procedure 
l-Phenyl-3-(2-methylphenyl)thiourea, 58a (2.4 g, 
0.01 mol), malonic acid (1.04 g, 0.01 mol) and acetyl 
60 
chloride (10 ml) were refluxed on a steam bath for 20 
minutes. The reaction mixture on cooling and treatment 
v;ith crushed ice solidified, v/as filtered, dried and 
recrystallised from acetic acid - ethanol to give 59a 
64 
as yellow solid, 2.4g(80%) m.p. 256-57° (lit. m.p. 
257°). 
l-Phenyl-3-(3-methylphenyl)-l-3-dihydro-2-thioxo-2H,5H-
64 pyrimidine-4,6-dione (59b) 
l-Phenyl-3-(3-methylphenyl)thiourea, 58b, (2.4 g) 
on condensation with malonic acid (1.0 g) in presence 
of acetyl chloride gave 59b as yellow crystalline 
solid, 2.3 g, m.p. 248-49° (lit^ '* m.p. 248°). 
1-Pheny1-3-(4-methylphenyl)-1,3-dihydxo-2-thioxo-2H,5H-
64 pyrinu.dine-4,6-dione (59c) 
l-Phenyl-3-(4-methylphenyl) thiourea, 58c (2.4 g) 
on condensation with malonic acid (1.0 g) in presence 
of acetyl chloride gave 59c as yellow crystalline 
solid, 2.4 g, 262-63° (lit.^^ m.p. 262°). 
61 
l-PhenYl-3-(S-chlorophenyl)-1,3-dihydro-2-thioxo-2H,5H-
64 pyrimidine-4,6-dione (59d) 
l-Phenyi-3-(3-chlorophenyl)thiourea, 58d (2.6 g) 
on condensation with malonic acid (1.0 g) in presence 
of acetyl chloride gave 59d as yellow crystalline 
solid, 2.7 g, m.p. 256-57° (lit.^'* m.p. 257°). 
l-Phenyl-3-(4-chlorophenyl)-l,3-dihydro-2-thioxo-2H,5H-
64 pyrimidine-4,6-dione (59e) 
l-Phenyl-3-(4-chlorophenyl)thiourea, 59e (2.6 g) 
on condensation with malonic acid (1.0 g) in presence 
of acetyl chloride gave 59e as yellov/ crystalline 
solid, 2.6 g, m.p. 260-61° (lit.^"^ m.p. 262°). 
l-Phenyl-3-(4-bromophenyl H-,3-dihydro-2-thioxo-2H,5H-
pyriniidine-4,6-dione (59f) 
l-Phenyl-3-(4-bromophenyl)thiourea, 59f (3.0 g) 
on condensation with malonic acid (1.0 g) in presence of 
acetyl chloride gave 59f as yellow crystalline solid, 
3«0 g,in.p. 257-58° (lit.^^ m.p. 257°). 
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Synthesis of l,3-diaryl-5-chloroacetyl-i,3-dihydro-2-
thioxo-2H,5H-pyrimidine-4,6-diones (60a-f) 
1-Pheny1-3-(2-methyIpheny1)-b-chloroacetyl-1,3-dihydro-
2-thioxo-2H,5H-pyrimidine-4,6-dione (60a) 
1-Phenyl-3-(2-methyIpheny1)-1,3-dihydro-2-thioxo-
2H,5H-pyrimidine-4,6-dione, 59a (3.1 g, 0.01 mol), dry 
triethylamine (0.1 ml) in dry benzene (50 ml) and 
chloroacetyl chloride (0.2 ml) were refluxed for 30 
minutes. The solvent v/as removed under reduced pressure 
and the residue was treated with water. Solid thus 
separated was filtered and recrystallised from benzene-
petrol to give 60a as light yellov/ solid, yield, 3.0 g 
(72%), m.p. 210-11°. 
"H-NMR (CDCl^) S 2.15 (3H, s, 2-CH^), 4.9 
8 
-6-CH2CI) , (2H, s, 
7.05-7.75 (lOH, m, Ar-H and 
5-H) . 
l-Phenyl-3-(3-methylphenyl)-5-chloroacetyl-l,3-dihydro-
2-thioxo-2H,5H-pyrimidine-4,6-dione (60b) 
l-Phenyl-3-(3-methylphenyl)-l,3-dihydro-2-thioxo-
2H,5H-pyrimidine-4,6-dione, 59b (3.1 g) on condensation 
with chloroacetyl chloride (0.2 ml) in dry benzene gave 
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a s o l i d v;hich v;as cr^ s t a l l i s e d f rora b e n z e n e - p e r r o l t o 
g i v e 60b a s ye l lov ; c r y s t a l s , 2 .9 g , m . p . 2 1 3 - 2 1 4 ° . 
-•-H-NMR (CDCl,) 6 : 2 .35 (3H, 5 , 3-CK^1, 5 .05 (2H, s , 
-C-CH2-CI) , 7 . 0 - 7 . 9 (lOH, m, Ar-H 
and 5 - H ) . 
l-Phenyl-3-(4-methylphenyl)-5-chloroacetyl-l,3-dihydro-2-
thicBco-2H, 5H-pyriinidine-4 / 6-dione {60c) 
l-Phenyl-3-(4-methylphenyl)-l,3-dihydro-2-thioxo-
2H,5H-pyrimidine-4,6-dione, S9c (3 J. g) on condensation 
v^ ?ith chloroacetyl chloride (0.2 ml) in dry benzene gave 
a solid which was recrystallised from benzene-petrol to 
give 60C as yellow crystalline solid, 3.0 g, m.p. 
230-31°. 
"""H-NMR (CDCl^+TFA) S : 2.45 (3H, s, 4-CH^), 5.1 (2H, s, 
-C-Cn^Cl) 7.1 to 7.8 (lOH, m, Ar-H 
and 5-H). 
l-Phenyl-3-(3-chlorophenyl)-5-chloroacetyl-l,3-dihydro-2 
-thioxo-2H,5H-pyrimidine-4,6-dione (60d) 
l-Phenyl-3-(3-chlorophenyl)-1,3-dihydro-2-thioxo-
2H,5H-pyrimidine-4,6-dione, 59d (3.3 g) on condensation 
with chloroacetyl chloride (0.2 ral) in dry benzene gave 
64 
a solid, recrystallised fron benzene-petrol to give 60d 
as yellow crystalline solid, 2.9 g, m.p. 213-14°. 
c 
•'•H •NMK(CDCl3) S : 5.1 (2H, s, -C-CH2CI), 7.25-7.85 
(IOK, n, Ar-H and S-H). 
l-Phenyl-3-(4-chlorophenyl)-5-chloroacetyl-l,3-dihydro-
2-thioxo-2H, 5H-pyriniidine-4 ,6-dione ( 60e) 
« 
1-Phenyl-3-(4-chlorophenyl)-l,3-dihydro-2-thioxo-
2K, 5H-pyririiidine-4 ,6-dione, 59e (3.3 g) on condensation 
X'lith chloroacetyl chloride (0.2 ml) in benzene gave a 
solid, v;hich v/as recrystallised from benzene-petrol to 
give 60e as yellov; crystalline solid, 2.8 g, m.p. 
248-49°. 
0 
H-NMR(CDCl2+TFA) f : 5.15 (2H, s, -C-CH2CI), 7.25-8.1 
(lOH, m, Ar-H and 5-H). 
I-Phenyl-3-( 4-broniophenyl)-5-chloroacetyl-l, 3-dihydro-2-
thioxo-2H, 5H-pyriniidine-4 , 6-dione (60f) 
l-Phenyl-3-(4-bromophenyl)-l,3-dihydro-2-thioxo-
2H , 5Fi-pyrinidine-4 , 6-dione , 59f (3.7 g) on condensation 
with chloroacetyl chloride (0.2" ml) in dry benzene gave 
a solid which \jas recrystallized from benzene-petrol to 
give 60f as yellov^ crystalline solid 2.5g, m.p. 250-51°. 
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•"•H-NMRCCDCl^+TFA) 5 : 5.05 (2H, s, -C-CH^-Cl) , 7.35-
8.15 (lOH, m, Ar-H and 5-H). 
Synthesis of l,3-dia£yi-l,3-dihydro-5-(2-niercaptothiazol 
4-yl) -2-thioxo-2H, 5H-pyriinidine-4,6-diones ( 61a-f) 
l-Phenyl-B-(2-methYlpheny1)-1,3-dihydro-5-(2-mercapto-
thiazol-4-y 1) -2-thioxo-2H, 5H-pyriniidine-4,6-dione (61a) 
5-Chloroacetyl derivative 60a (0.38 g, 1 mmol) and 
amriionium dithiocarbamate (0.11 g, 1 mmol) were 
refluxed in absolute ethanol (25 ml) on a steam bath for 
3 hr. Solvent was distilled off and residue was treated 
with water. The solid thus obtained v/as filtered, 
crystallised from ethanol to give 61a as v;hite 
crystalline solid, yield, 0.27 g (71%) m.p. 279-80°C. 
IR V ^ ^J°l cm"-^  : 2450, 1720, 1645, 1600. 
max 
H-NMR (CDCl^+DMSO 6)g : 2.15 (3H, s, 2-CH^), 4.8 (IH, 
s, DpO exchangeable SH), 
7.0-7.9 (llH, m, Ar-H, 5-H, 
5'-H). 
Analysis : C20^15'^3°2^3 ^^^^^^^^ C, 57.4 ; 
H, 3.5; N, 9.6%.. Found : C, 
57. 3 H, 3.75; N, 9.6%. 
66 
following compounds viz. (61b-f) were prepared by 
similar procedure. 
l-Phenyl-3-(3-methylphenyl)-1,3-dihydro-5-(2-mercapto-
thiazol -4-yl-2-thia}co-2H,5H-pyrimidine-4,6-dione (61b) 
Condensation of 5-chloroacetyl derivative, 60b 
(0.38g, 0.001 mol) with ammonium dithiocarbamate (O.llg, 
0.001 mol) in absolute ethanol gave 61b which was 
crystallised from ethanol as white solid, 0.23g, m.p. 
251-52°C. 
I.R. S) ^ "^ol j^^ -1 . 2400, 1725, 1640, 1680 
max 
1H-NMR(CDC13-DMS0^6 3^ ^ 2.18 (3H, s, 3-CH3), 4.75 (IH, 
s, SH), 7.2-7.85 (llH, m, Ar-H, 
5-H, 5'-H). 
Analysis : C_„H-. cN-jO^ S requires C,57.4,-
H, 3.5; N, 9.8%. Found : C, 
5 7.3; H, 3,5 ; N, 9.8%. 
l-Phenyl-3-(4-methylphenyl)-1,3-dihydro- 5-(2-raercapto-
thiazol-4-yl)-2-thioxo-2H,5H- jyrimidine-4,6-dione (61c) 
Condensation of 5-chloroacetyl de r iva t ive , 60c 
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(0.38, 0.001 mol) with airanonium dithiocarbanate (O.llg, 
0.001 mol) in absolute ethanol gave 61c v/hich was 
crystallised from ethanol as white crystalline solid, 
0.22g, m.p. 210-212°C. 
_ ^ ., Nujol -1 I.R. V -• cm 
max 
2450, 1726, 1640, 1600 
'H-NMRCCDCl^) S 2.35 (3H, S, 4-CH3), 4.8 (IH, 
s, 8H), 7.1-7.5 (IIH, m, Ar-H, 
5-H, 5'-H). 
Analysis ^20^15^3*^2^3 requires, C, 
57.4 : H, 3.5 ; N, 9.8 . 
Found : C, 57.2 ", H, 3.6 ; N, 
9.6. 
l-Phenyl-3-(3-chlorophenyl)-1,3-dihydro-5-(2-mercapto-
thiazol -4-yl)-2-thioxo-2H,5H-pyrimidine-4,6-dione (61d) 
Condensation of 5-chloroacetyl derivative 60d 
(0.41g, 0.001 mol) with ammonium dithiocarbamate (O.llg, 
0.001 mol) in absolute ethanol gave 61d v^ hich was 
crystallised from ethanol as v/hite crystalline solid, 
0.29g, m.p. 240-43°C. 
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^ _ ,^ Nuiol -1 l.i\. y -' cm 
max 
2400, 1740, 1680, 1600 
H-NMRCCDCl^) S A.15 (IH, s, SH), 7.4-7.9 (llH, 
m, Ar-H, 5'-H and 5-H). 
Analysis : C,QH,„C1N^0„S^ requires C, 55,d7; 
H, 2.89; N, 10.14. Found : C, 
55.02; H, 2.84; N, 10.01%. 
1-Pheny1-3-(4-chloropheny1)-1,3-dihydro-5-(2-mercapto-
thiazol-4-yl) -2-thioxo-2H, 5H-pyriniidine-4,6-dione ( 61e) 
Condensation of 5-chloroacetyl derivative, 60e 
(0.41g, 0.001 mol) with ammonium dithiocarbamate (0.11 
g, 0.001 mol) in asbolute ethanol gave 61e which v;as 
crystallised from ethanol as white solid, 0.28g, m.p. 
195-96°C. 
T T^  M N u i o l -1 I .R. ^  -' cm 
max 
2450, 1740, 1690, 1650, 1600 
"H-NMR(CDCl2)S 4.75(1H, s, SH), 7.4-7.9 (llH, 
m, Ar-H, 5-H, 5'-H). 
Analysis C-,QH-, „C1N_,0^ S^  requires C, 55.07; 
H, 2.89; N, 10.14. Found : C, 
55.06; H, 2.81; N, 10.10%. 
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l-Phenyl-3-(4-bromophenyl)-1,3-dihydro-5-(2-mercapto-
thiazol-4-yl) -2-thioxo-2H, 5H-pyriniidine-4,6-dione (61f) 
Condensation of 5-chloroacetyl derivative, 60f 
(0.45g, 0.001 mol) with ammonium dithiocarbamate (O.llg, 
0.001 mol) in absolute ethanol gave 61f crystallised 
from ethanol as white solid, 0.29g, m.p. 175-76°C. 
I.R. ^ ^^^°^cm~^ : 2375 1740, 1700, 1600. 
max 
•'•H-NMR(CDCl3+DMS0^6) <S : 4.75 (IH, s, SH), 7.0-7.9 (llH, 
m, Ar-H, 5'-H, 5-H). 
Analysis : Cj^gH^2^^ ^3°2^3 requires C, 
49.78; H, 2.62; N, 9.17. 
Found : C, 49.67; H, 2.59; N, 
9.11%. 
Synthesis of l,3-diaryl-l,3-dihydro-5-(2-methylthiazol-
4-yl)-2-thioxo-2H,5H-pyrimidine-4,6-diones (62a-f) 
l-Phenyl-3-(2-methylphenyl)-1,3-dihydro-5-(2-methyi-
thiazol -4-yl)-2-thioxo-2H,5H-pyrimidine-4,6-dione (62a) 
5-Chloroacetyl thiobarbituric acid, 60a (0.38g, 
0.001 mol) and thioacetamide (0.075g,0.001 mol) were 
refluxed in absolute ethanol (50 ml) on a steam bath for 
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3.5 hr. Solvent \jas removed under reduced pressure and 
the residue was treated \;ith water, filtered and dried. 
The solid obtained was recrystalized fron chloroforn-
methanol to gi^re 62a as v/hiLe crystalline solid, O.279, 
m.p. 196-198°C. 
T R V Nujol -1 1 .K. V cm 
max 
1740, 1680, 1600, 1500, 760, 700 
"'"H-NMR(CDCl^) S 2.3 (3H, s, Ar-CH^), 2.8 (3H, 
s, 2'-CH^), 7.15-7.95 (lOH, m, 
Ar-H), 8.4 (IH, s, 5'-H). 
Analysis C^jll-.^U^OS^ requires C, 72.00; 
K, 4.85; N, 12.0. Found: C, 
71.01; H, 4.78, N, 11.91%. 
l-Phenyl-3-(3-methylphenyl)-1,3-dihydro-5-(2-methyl-
thiazol-4-yl)-2-thioxo-2H,5H-pyrimidine-4,6-dione (62b) 
Condensation of 5-chloroacetyl derivative 60b 
(0.38g, 0.001 mol) with thioacetaraido (O.Q75g, 0.001 mol) 
in absolute ethanol gave 62b v;hich was recrystallised 
from chloroform methanol as \/hitG crystalline solid; 
0.2 5g, m.p. 249°. 
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•'-H-NMR(CDCl3) S • 2.35 (3H, s, CH3), 2.65 (3H, s, 
CH3), 7.3-7.5 (lOH, m, Ar-H), 
8.4 (IH, s, 5'-H). 
Analysis : ^2l'^17^3^2^2 requires C, 
72.00; H, 4.85; N, 12.00. 
Found : C, 72.6; H, 4.82; N, 
11.95%. 
l-Phenyl-3-(4-methylphenyl)-1,3-dihydro-5-(2-methyl 
thiazol-4-yl)-2-thioxo-2H,5H-pyrimidine-4,6-dione (62c) 
Condensation of 5-chloroacetyl derivative 60c (0.38g, 
0.001 mol) with thioacetamide (0.075g, 0.001 mol) in 
absolute ethanol gave 62c which was recrystallised from 
chloroform methanol as v/hite solid; 0.22g, m.p. 
257-59°C. 
•"•H-NMRCCDCl^) S : 2.3 (3H, &; Ar-CH^), 2.6 {3H, 
s, S'-CH^), 7.1-7.7 (lOH, m, 
Ar-H), 8.5 (IH, s, 5-H). 
^"^^y^^^ •  C2iH^^N302S2 requires C, 72.00; 
H, 4.85; N, 12.00. Found : C, 
71.7; H, 4.83; N, 11.92%. 
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l-Phenyl-3-(3-chloropheny1)-1,3-dihydro-5-(2-raethyl-
thiazol-4-yl)-2-thioxo-2H,5H-pyrimidine-4,6-dione (62d) 
Condensation of 5-chloroacetyl derivative 60d 
(0.4ig, 0.001 mol) with thioacetamide (O.DVSg, 0.001 mol) 
in absolute ethanol gave 62d which was crystallised from 
chloroform methanol as white solid, 0.29g, ro.p. 192°C. 
^H-NMR(CDCl3) S ' 2.8 (3H, s, 2'-CH^), 7.0-7.6 
(lOH, m, Ar-H), 8.0 (IH, s, 
5'-H). 
Analysis : C^ _?:. ,ClN^O_S^ requires C, 56.20; 
H, 3.27; N, 9.80. Found : C, 
56.30, II, 3.20; n, 9.79% • 
l-Phenyl-3-(4-chlorophenyl)-1,3-dihydro-5-(2-methyl-
thiazol -4-yl)-2-thioxo-2H,5H-pyrimidine-4,6-dione (62e) 
Condensation of 5-chloroacetyl derivative 60e 
(0.41g, 0.001 mol) v^ ith thioacetamide (0.075g, 0.001 
mol) in absolute ethanol gave 62e which was crystallised 
from chloroform methanol as white solid, 0.28g, m.p. 
240-43°C. 
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^H-NMR(CDCl3)^ : 2.75 (IH, s, 2'-CH3), 7.2-7.7 
(IH, m, Ar-H), 8.1 (IH, s, 
5"-H). 
Analysis : C20H14CI N3O2S2 requires C, 
56.20; H, 3.27; N, 9.80; Found 
: C, 56.19; H, 3.26; N, 9.79%. 
l-Phenyl-3 -(4-bromopheny 1H-, 3-dihydro-5- ( 2-methyIthiazol-
4_yl-)_2-thioxo-2H,5H-pyrimicline-4,6-dione (62f) 
Condensation of 5-chloroacetyl derivative 60f 
(0.45g, 0.01 mol) with thioacetamide (0.075g, 0.001 mol) 
in absolute ethanol gave 62f which was crystallised from 
chloroform methanol as white solid 0.32g, m.p. 200 
(d.)°C. 
^H-NMR(CDCl3) S : 2.95 (3H, s, 2'-CH3), 7.1-7.9 
(lOH, m, Ar-H), 8.55 (IH, s, 
5*-H). 
Analysis : C H Rr N n Q ^^ • „ 
20 14 3 2 2 requires C, 
50.84; H, 2.96; N, 8.89. 
Found : C, 50.82, H. 2.92; N, 
8.85%,. 
74 
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CHAPTER III 
Synthesis of 5-hydroxy-l,3-diaryl-l,2,3,4,5-pentahydro-
10-methyl-4-oxo-2-thioxopyrimido(4,5-b)quino line 
Introduction 
Remarkable and significant biological activities 
have been observed in pyrimidines and substances with 
fused pyrimidine ring. Some pyrimidine derivatives like 
pyrido (2,3-d) pyrimidines (1) have pyrimidine nucleus 
fused with nitrogen containing ring. This type of 
compounds v/ere initially synthesised v^ ith a view to study 
the biological activity and physiological properties 
because of their close structural similarities v/ith 
1 2 quinazolines and pteridines. ' Since then a v/ide 
variety of applications have been reported/ the pyrido 
(3, 2-d) pyrimidines and a large number of (2, 3-d) 
pyrimidines were found to be highly active against a 
9-12 
variety of pathogenic bacteria. A number of patents 
refer to the antipyretic, diuretic, bacteriostatic 
sedative and coronary dilating activities of a series of 
a tetrahydropyrido (4,3-d) pyrimidines. 
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8 
/ 
iN' 
5 4 
(1) 
quinazolines 
8 
v> N^  ,2 
^5 
5 • 4 
pteridines 
A number of deaz a-analogues of pteroic acid (2) have been 
13 prepared and examined by Radon et al. as antagonist of 
folic acid in streptococcus faccalis and lactobacillus 
c a s e i . 
' 0 
II 
HCM:-
N^^  
r^ N H C H ^ 
OH 
2) 
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The pyrido (3,2-d) pyrimidines (3) have been shown .to possess 
significant antifolic acid activity. 
^N^NH^ 
_\V_NHCh^-^^x::::N 
R = H or Et 
(3) 
V'Jork has shown that pyrido (2,3-d) pyrimidines (4) 
possess antibacterial activity. The action of such 
compounds is potentiated by sulphonamides and such a 
combination of drugs is active against both penicillin-
resistant and penicillin sensitive strains of 
staphylococcus aureus. 14 
(4) 
R - alkyl, H. 
Pyridopyrimidine (5) has been used widely as potent 
inhibitor of dihydrofolate reductase and has minimum 
^tiects on Taistamin levels. 
15 
84 
(5) 
Some other derivatives of the type (6,7) have been used 
as effective analgesics, antihypertensives and anti-
depressants. 
0 C H^OH 
t 
PM 
(5) R = alkoxy, Mes (7) 
R^ = alkyl 
Pyrido (2,3-d) pyrimidine dione derivatives (8) have been 
found to possess analgesic and anti-inf laminatory 
^ • . , • 17 ,18 
activities 
R, = H, halo, alkyl,OH 
R„ = Ph, cycolhexyl 
sub&benzyl, alkyl, 
halo,•OH etc. 
(8^ 
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19 Antibacterial activities have been studied in pyrido 
(2,3-d) pyrimidines of type (9 ). 
R = CI, alkoxy, 
pyrrolidine etc. 
R, = OH, MeO, HOCH„-
CH^NH 
(9) 
Pyrimidines in fusion with quinolines have also acquired 
considerable interest in pharmaceutical field. Various 
quinoline derivatives themselves (10, 11) have been used 
as antimalarial, antischistomal and antifilarial 
^ 20 ,21 
agents 
CI 
HN N NH 
\ / ' 
(10) 
(11) 
R = CO2H 
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22 Quaternary pyrimido (4,5-b) quiniliniun salts (12) are 
found to be bactericidal. 
X" 
(12) 
Pyrimido (4,5-b) quinoline dio.nes (13) have been 
discovered in 5-deazaflavin moietycfF.^ which is the co-
enzyme of methane producing bacteria 23 
(13) 
Earlier methods of synthesis 
R, = alkyl, CH^ etc, 
^ R„ = H, Halogen etc. 
A number of methods have been adopted for the 
synthesis of pyrimidoquinoline^ few of them are discussed 
below. 
87 
23 1. A versatile procedure for the synthesis of such 
compounds involves the oxidative coupling of 5,5'-
arylmethylenebis-(6-alkYlamino-3-methyl uracils) (15), 
prepared by the condensation of 6-alkylamino-3-methyl 
uracils (14) and arenecarbaldehydes, with diethyl 
azodiformate (DAD) affording the corresponding pyrimido 
(4,5-b) quinoline (16) or 5-deaza flavins. This 
synthetic method has been successfully applied to the 
preparation of 5-deazaflavin-type compounds such as 
benzologue, a thiophen analogue, or a nitrogen analogue 
of 5-deazaflavin. 
MeN 
0 
H 
Ar-CHO MffN 
^NHR, L ^ H H 
H Ri R H 
IMe 
( 1 4 ) ( 1 5 ) 
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DAD 
^ 
McW 
R, = Me 
(16) 
2. Another method for the synthesis of pyrimido-
quinolines^^ involves the cyclisation of pyrimidine 
derivative (17) with polyphosphoric acid to give the 
pyrimido quinoline (18). 
PPA 
(17) 
?h 0 
(18) 
H Ph 
3. Treatment of 6-(N-alkylanilino)-2-phenyl pyrimidine-4 
(3H) ones (19) which were prepared by the condensation of 
6-chloro-2-phenyl pyrimidine-4 (3H)one v;ith alkylaniline, 
with the vilsmeier reagent gave the 5-deazaflavins' 
(20). 
25 
89 
(19) (20) 
.26 4. This method"' consists of the reaction of 6-aryl 
arninouracil(21) with 4-R-CgH^CHO (22) which provided 
pyrimido(4,5-b) quinolines (23). 
Q 
MeN 
Me H 
4- CHO- < ^ 
-> 
(21) 
MeN 
(22) 
R = H, Me, MeO 
23) 
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5. Using the corresponding 5-nitrouracils(24) and DMF in 
phosphoryl bromide at 130°C allows substitution of the 
27 
nitro group to give pyrirrddo(4,5-b)quinoline (25). 
MeN' Me 
DMF,POBr^ ' ? 
130°C, Ih ^ J ^ 
(24) R = alkyl (25) 
Object of the present work 
Significant physiological and biological activities 
have been studied in pyrimidine compounds fused to 
different nitrogen containing heterocycles such as 
pyridopyrimidines, pyrrolopyrimidines etc. Pyrimido 
quinolines have become a subject of active research in 
recent years. This provided an impetus to the synthesis 
of compounds containing these structural features, in 
view of the biologicl and physiological importance 
associated with thiobarbiturates, it v/as considered of 
interest to synthesise the compounds containing 
thiobarbiturates fused with quinoline. 
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Present Work 
The present work describes a convenient synthesis 
of 5-hydroxy-l,3-diaryl 1,2,3,4,5-pentahvdro-lO-methyl 
-4-oxo-2-thioxo-Pyriraido (4,5-b) quinoline (28a-f),by 
the condensation of corresponding 
6-chlo^o-5-formylpyriinidines (26a-f) with 
N-methylanilines. The required l,3-diaryl-l,3-dihydro-6-
chloro-5-formyl-2-thioxo-2H,5H-pyrimidine 4,6-diones 
(26a-f) were synthesised by the reaction of appropriate 
thiobarbituric acid with Vilsmeier reagent. Different-
l,3-diaiyl-2-thiobarbituric acids were prepared by the 
condensation of 1,3-diaryl thiourea with malonic acid as 
described in chapter I. 
Synthesis of 6-chloro-l,3-diaryl-5-formyl-2-thiouracil 
(26a-f) 
As a typical case, 1,3-diphenyl-2-thiobarbituric 
acid (25a) when treated with POCl^/DMF gave a pale yellow 
solid which analysed for C-, yH, , ClN^O^S. It was found 
to contain chlorine. The aldehydic group was evidenced 
by the positive DNP test and -""H-NMR singlet at <5 9.90. 
The 'H-NMR spectra was otherwise also in agreement with 
the 6-chloro-l,3-diphenyl-5-formyl-2-thiouracil (26a). 
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v f-R 
S v ^ ^ 
POCl^/Dl-iF 
K 
( 2 5 a - f ) 
( a ) R = H 
( b ) R = 4 - B r 
( a ) R = 4 - C l 
( 2 6 a - f ) 
( d ) 2-OCH3 
( e ) 3-CH3 
( f ) . 4 - C H 3 
Synthesis of 5-hydroxy-l,3-diary1-1,2,3,4,5-pentahydro-
10-methyl-4-oxo-2-thioxopyrimido (4,5-b) quinoline(28a-f) 
In a typical case, 6-chloro-l, 3-diphenyl-5-formyl-
2-thiouracil (26a) was condensed with N-methylaniline to 
give white solid. The I.R. spectrum of the solid had 
shown band at 1705 cm fcr >C=0 group and at 341 & 
cm for-OH group. In the 'H-NMR spectrum N-CH-, protons 
appeared at S 2.80. The singlet at f 5.40 for one proton 
was assigned to 5-H. Aromatic protons gave multiplets at 
56.90-7.70 integrating for 14 protons. The above spectral 
data and elemental analysis led to its formulation as 
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5-hydroxy-l,3-diphenyl-l,2,3,4,5-pentahydro-10-methyl-4-
oxo-2-thioxopyrimido {4,5-b) quinoline (28a). The 
presence of the hydroxy group at C-5 position was 
confirmed by acetylation of (28a) in the presence ot 
AC2O/PY to give (29a). In '^ H-NMR a 3H singlet for acetyl 
group appeared at S 2.4 and the structrue was formulated 
as 5-Acetoxy-l,3-diaryl 1,2,3,4,5-pentahydro, 10-methyl-
4-oxo-2-thioxopyrimido (4,5-b) quinoline (29a). 
The other pyrimido (4,5-b) quinolines (28b-f) were 
prepared in a similar manner and the structures were 
formalted on the basis of spectral deta and elemental 
analysis. 
IR 
?^!5 
SwKi^^X:! H-N 
(27) 
(26a-f) (28a-f) 
(a) 
( b ) 
( c ) 
( d ) 
( e ) 
( f ) 
R = H 
R = 4 - B r 
R = 4 - C l 
R = 2-OCH 
R = 3CH 
R = 4 - C H ^ 
R-
?H^ 
1 '^ '' ^  
R cO IH 
(29a ) 
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EXPERIMENTAL 
Synthesis of 1,3-diarylthiobarbituric acids {25a-f) 
See Chapter J, Experimental Section. 
Synthesis of 6-chloro-l,3-diaryl-5-formyl-2-thiouracil 
(26a-f) 
6-chloro-l, 3-diphenyl-5-forTnyl-2-thiouracil (26a) 
l,3-Diphenyl-2-thiobarbituric acid (25a, 2,98 g, 
0.01 mol) in dimethylformaraide (11 ml) was cooled to 0°C 
in an ice-acetone bath. Phosphorous oxychloride (4.62 
ml, 0.03 mol) v;as then added to it dropv;ise, maintain^ 
the temperature betv/een 1G-20°C. The reaction mixture 
was refluxed for 45 minutes. After cooling, it was 
poured over crushed ice and left overnight at room 
temperature. The solid thus obtained was filtered, 
v/ashed with water dried and recrystallised from methanol 
as pale yellow flakes of 26a (2.7g, yield 75%), n.p. 
224-225°C. 
K-m-.R (CDCI3) <S : 7.15-7.9 (lOH, m, Ar-H), 9.90 (IH, 
S, CHO). 
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Analysis : Calculated for C^-,H^^C1N202S : C, 
59.6; H, 3.2; N, 8.1. Found : C, 
59.7; H, 3.3; N, 8.2%. 
6-chloro-l,3-di(4-bromophenyl)-5-formyl-2-thiouracil(26b) 
l,3-Di(4-bromophenyl)-2-thiobarbituric acid (25b, 
4.54g, 0.01 mol) was refluxed with dimetyl formamide (11 
ml) and phosphorous oxychloride (4.62 ml) for 45 min. 
The reaction mixture V7as worked up with ice to give 
yellow solid v/hich was recrystallised from benzene petrol 
as yellow crystals of 26 b (2.8 g, yield 70%) m.p. 110°C 
(d). 
•"•H-NMR (CDCI3) 6 : 7.15-7.70 (8H, m, Ar-H), 9.95 (IH, 
S, CHO). 
Analysis : Calculated for C,-HgBr2ClN202S : 
C, 40.8; H, 1.8; N, 5.6. Found : 
C, 41.0; H, 1.6; N, 5.4%. 
6-chloro-l,3-di(4-chlorophenyl)-5-formyl-2-thiouracil 
(26c) 
1,3-Di(4-chlorophenyl)-2-thiobarbituric acid (25c, 
3.65 g, 0.01 mol) was refluxed v^ ith dimethylformamide and 
phosphorous oxychloride and worked up following the same 
procedure as in previous case. The solid obtained was 
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recrystallised from benzene petrol as yellow crystals of 
26c (2.78g, yield 68%) m.p. 190-91°C. 
^H-NMR (CDCl^) E : 7.10-7.65 (8H, m, Ar-H), 9.90 (IH, 
•3 
S, CHO) 
Analysis : Calculated for C^jE^Cl^l^^^2^ ' ^' 
49.8; H, 2.2; N, 6.8. Found : C, 
49.7; H, 2.3; N, 6.9%. 
6-chloro-l,3-di(2-nethaj^phenyl)-5-formyl-2-thiouracil 
(26d) 
1,3-Di(, 2-methoxyphenyl)-2-thiobarbituric acid (25d, 
3.5 6g .01 mol) v/as refluxed with dimethyl formamide and 
phosphorous oxychloride and the reaction mixture \\?as 
worked up with ice as in previous case to give yellow 
solid recrystallised from benzene-petrol as yellow 
crystals of 23d (2.0g, yield 67%), m.p. 101°C (d). 
•^ H-NMR (CDCI3) i : 3.9 (6H, S, 2xOCH ) , 6.5-7.7 (8H, 
m, Ar-H), 10.1 (IH, S,CHO). 
Analysis : Calculated for C^ g^H-j^ C^lN 0 S : C, 
42.3, H, 4.9; N, 9.2; Found : C, 
42.2 H, 4.7; N, 4.1%. 
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6-chloro-l, 3-di {3-methylphenyl) -5-f ormyl-2-thiouracil 
(26e) 
1,3-Di(3-methylphenyl)-2-thiobarbituric acid (25e, 
3.2g, 0.01 mol) was refluxed with dimethyl formamide and 
phosphorous oxychloride and the reaction mixture was 
worked up with ice to give yellow solid recrystallised 
from benzene-petrol as yellow crystals of 23 C (26g, 
yield 70%) m.p. 210-12°C. 
•^ K-Nr4R (CDCI3) S : 2.3 (6H, S, 2XCH3) , 6.5-7.5 (8H, 
m, Ar-H), 10.2 (IK, S, CHO). 
Analysis : Calculated for C^gH^^ClN202S : C, 
61.6; K, 4.0; N, 7.5. Found : C, 
61.4; H, 4.3; N, 7.2%. 
6-chloro-l/3-di(4-methylphenyl)-5-formyl-2-thiouracil 
(26f) 
1,3-Di(4-methylphenyl)-2-thiobarbituric acid (25f, 
3.2g, 0.01 mol) was refluxed with dimethyl formamide and 
phosphorous oxychloride and the reaction mixture was 
v/orked up v^ ith ice following the same procedure as in 
previous cases to give yellow solid recrystallised from 
benzene-petrol as yellow crystals of 23f (2.5g, yield 
67%) m.p. 132° (d). 
1,. K-NMR (CDCl^) B 
Analysis 
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: 2.35(6H, S, 2XCH3), 6.5-7.7 (8H, 
m, Ar-H), 10. Id?;, S, CKO). 
: Calculated for C^gH^^ClN202S : C, 
61.6; K, 4.0; N, 7.5. Found : C, 
51.3 ; H, 4.2; N, 7.2%. 
5-hydroxy-l,3-diphenyl-l,2,3,4,5-pentahydro-10-methyl-4-
oxo-2-thioxopyrimido (4,5-b) quinoline (28a) 
A mixture of the 6-chloro-5-formyl-2-thiouracil 
(26a, 0.34g, 0.001 mol) and the N-methylaniline (3.3g, 
3.3 ml, 0.03 mol) was heated at 80°C for half an (>our 
with stirring. It was allowed to cool and ether (10 ml) 
was added and the mixture was stirred further for 1 hr at 
room temperature. On addition of water solid \;as 
separated out which was filtered, dried and 
chromatographed on a silica gel column using CHCl,; as 
eluent to give a white colour solid, 28a, yield 0.30g 
(83%) m.p. 174-76°C. 
F . T I . R . -Cj^^^ (KBr) cm"-"": 3 4 1 6 . 6 , 1 7 0 5 . 2 , 1 6 3 2 . 2 , 
1 6 0 3 . 3 , 1 3 2 3 . 9 , 7 5 1 . 8 , 6 0 1 . 9 . 
•H-NMR (CDCI3) K : 2 . 7 5 (3H , S , N - C H 3 ) , 5 . 4 ( I H , 
S , 5 - H , D2O u n e x c h a n g e a b l e ) 
6 . 8 - 7 . 7 ( 1 4 H , m, A r - H ) . 
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Analysis Calculated for C24Hj^gN202S : 
C, 69.7; H, 4.6; N, 10.1. 
Found : C, 69.5, H, 4.7; N, 
10.3%. 
5-hydroxy-l,3-di(4-bromophenyl)-1,2,3,4,5-pentahydro-lO-
methyl-4-oxo-2-thioxopyrimido (4,5-b) quinoline (28b) 
Condensation of 6-chloro-5-formyl-2-thiouracil 
(26b, 0.50g, 0.001 mol) and the N-methylaniline (0.03 
mol) following the same procedure as above gave 28b as 
white solid, yield 0.45g (78%) m.p. 197(d). 
T- „ .Nujol -1 I.R. "V -• cm 
max 3400, 1700, 1650, 1620, 1320, 
740, 700, 600. 
"^ H-NMR (CDCl^) & 2.80 (3H, S, N-CH^), 5.35 (IH, 
S, 5-H), 6.45-7.75 (12H, m, 
Ar-H). 
Analysis Calculated for C24H-|^^Br2N20 S: 
C, 50.4; H, 2.9; N, 7.3. 
Found : C, 50.6; H, 2.7; N, 
7.0%. 
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5-hydroxy-l,3-di(4-chlorophenyl)-1,2,3,4,5-pentahydro-iO-
methyl-4-oxo-2-thioxopyrimido (4,5-d) quinoline (28c) 
Condensation of 6-chloro-5-f orinyl-2-thiouracil 
(26c, 0.41g, 0.001 mol) with the N-methylaniline (0.03 
inol) following the same procedure gave pale yellov/ solid 
of 28c, yieldD.38g (79%) m.p. 192-4°C. 
I.R. !^?"j?°''' cm"-'- : 3400, 17C0, 1660, 1625, 1375, 
1320, 755, 720 
max 
•""H-NMR (CDCl^) h : 2.80 (3H, S, N-CH^), 5.40 (IH, 
S, 5-H), 6.50-7.70 (12H, m, 
Ar-H) . 
Analysis : Calculated for Cp .H,-,Cl^N^OpS: 
C, 5 9.8; H, 3.5; N, 8.7. 
Found : C, 5 9.5; H, 3.6; N, 
8.5%. 
5-hydroxy-l, 3-di( 2-methoxyphenyl) -1, 2 , 3 , 4 , 5-pentahydro-lO-
methyl-4-oxo-2-thioxopyrimido (4,5-b) quinoline (28d) 
Condensation of 6-chloro-5-formyl-2-thiouracil 
(26d, 0.40g, O.OOl mol) and the N-methylaniline (0.03 mol) 
following the same procedure gave v^ ?hite solid of 28d 
0-36 g (77%) m.p. 137-9°C. 
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^ „ , NuTol -1 I.R. ^ -' cm 
max 
3400, 1705, 1620, 1370, 1320, 
750, 715. 
H-NMR (CDCl^) S 2.8 (3H, S, N-CH3), 3.90 (6H, 
S, 2XO-CH2), 5.45 (IH, S, 
5-H), 6.55-7.60 (12H, m, 
Ar-H). 
Analysis Calculated for C2gH23N20^S : 
C, 65.9; H, 4.8; N, 8.8. Found 
: C, 65.7; H, 5.0; N, -8.6%. 
5-hydroxy-l,3-di(S-methylphenyl)-1,2,3,4,5-pentahydro-lO-
methyl-4-oxo-2-thioxopyrimido (4,5-b) quinoline (28e) 
6-chloro-5-forinyl-2-thiouracil (26e, 0.37g, 0.001 
mol) was heated with N-methylaniline (0.03 mol) at 80°C 
for half an hour v/ith stirring. The reaction mixture was 
allowed to cool and on addition of ether and water gave a 
solid which was filtered dried and chromatographed on a 
silicagel column using CHCl^ as eluent to give a white 
solid, 28e, yield a33 g (76%) m.p. 200-02°C. 
-P P ) Nujol -1 1 .R. V -' cm 
max 3400, 1705, 1625, 1375, 1320, 
750, 720. 
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•'"H-NiyiR (CDCl^) S 2.35 (6H, S, 2XCH3), 2.75 (3H, 
S, N-CH3), 5.35 (IH, S, 5-H), 
6.45-7.5 (12H, m, Ar-H). 
Analysis Calculated for C2gH23N202S : 
C, 70.7; H, 5.2; N, 9.5. 
Found : C, 70.5; H, 5.3; N, 
9.7%. 
5-hydoxy-l,3-di(4-methylphenyl)-I,2,3,4,5-pentahydro-lO-
methyl-4-oxo-2-thioxopyrimido (4,5-b) quinoline (28f) 
Condensatin of 6-chloro-5-formyl-2-thiouracil (26f, 
0.37g, .001 mol) and the N-methylaniline (0.03 mol) 
follov\7ing the same procedure as above gave 28f as white 
solid, yield, 0.35 g (79%) m.p. 165-7 °C. 
_ ^ .Nujol -1 I. R. -\) -^  cm 
max 34 00, 1780, 1625, 1375, 1315, 
750, 720. 
•""H-NMR (CDCI3) S 
Analysis 
2.40(6H, S, 2XCH3), 2.75 (3H, 
S, N-CH3), 5.35 (IH, S, 5-H), 
6.5-7.6 (12, m, Ar-H). 
Calculated for C2gH23N30 S : 
C, 70.7; H, 5.2; N, 9.5; 
Found, C, 70.4; H, 5.1; N, 
9.8%. 
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CHAPTER IV 
Synthesis of 5-arylidene thiobarbituric acids, 5-
(pyrimidinyl) methylidene thiobarbituric acids and 
diarylpyranodipyrimidines as possible redox coenzyme models 
Introduction 
Redox reactions occurring in the biosystems are 
fundamental processes in maintaining the energy oalance in 
living organisms. Redox reaction taking place in a cell 
is a reversible reaction, catalysed by coenzymes. The 
coenzymes are nonopolar molecules acting as links between 
metabolic pathways in collaboration with enzymes. These 
actually serve as a catalyst in 'Biomolecular reactions'. 
The redox coenzymes act as dehydrogenating agents 
and change to the corresponding hydrogenated derivatives 
while the substrate gets oxidised. The coenzyme is again 
oxidised to the original form by the biosystems and the 
cycle continues as shown below (Scheme-I). 
AH^ \ / Coenzyme (oxidised) "^  /^ BH^ 
K i/ ' ^  Coenzyme (reduced) / V. 
A = first substrate; 'i^ - second substrate 
(Scheme - I) 
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Flavin residue is the one active part of flavin coenzyme 
FAD (flavin adenine dinucleotide) (Scheme - II). 
^^J^ 
N 
+ 2H 3 
"N-
N H^---/N 
R H 
!\JH 
H 
R = adenine dinucleotide residue 
(Scheme - II) 
Currently, flavin coenzymes have become the subject of 
very active research. The oxidation of alcohols to 
carbonyl derivatives is one of the many reactions \;hich 
occur in the presence of redox coenzymes i.e. FAD. In 
this reaction two different hydrogens of the substrate 
(alcohol) (one from carbon and the other from oxygen) are 
transferred to the flavin nucleus. In the mechanism, 
proposed by Hamilton"^, all the hydrogens are transferred 
as protons (Scheme-Ill). 
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P H 
/• NH 
1-130 
[-^ c 
+ 
V' 
H 
F^^^H 
F 2 
G ^ 
R-j^, Rp = a ] k y l or a r y l 
( S c h e m e - I l l ) 
Hamilton noted that the •>C=N bond of oxidised 
flavin resembled, in some respect, the ^C=N bond of any 
imme and m light of this similarity, he suggested that 
nucleophilic attack of a substrate at ^ C=N might provide 
a reasonable first step for the hypothetical mechanism of 
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enzymatic oxidation of substrate, mediated by flavin 
3 
coenzyme. Subsequent investigation on similar compounds 
have indicated that the ^C=N bonds are capable of 
electrophilic behaviour towards different nucleophiles. 
For studying the detailed mechanism of such behaviour, 
some analogous compounds (1), having electron withdrawing 
3 
substituent at carbon, have been prepared . 
4 5 Investigations ' revealed that the reaction of (1) 
with thioles viz. methylglycolate is extraordinarily fast 
relative to flavins. This remarkable increase in the 
reactivity of 5-arylidene barbituric acids (Scheme-IV) is 
attributed to the strongly electron withdrawing effect of 
NO2 in para position. 
(1) 
HSCH^COOCH^ 
25°C 
J^Or 
R = alkyl or aryl 
(Scheme IV) 
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Recently 5-deazaflavin (3) derivatives isolated 
from a natural source were shown to act as redox 
coenzymes. It has been recently discovered that they 
serve as cofactors for several flavin-catalysed reactions 
and that the coenzyme F.-n from methane producing 
bacteria possesses 5-deazaflavin nucleus. This has 
considerably aroused the interest and paved the v/ay for 
the synthesis of such compounds. Hence, this has further 
7 
led to the synthesis of compounds (4) and (5). 
(3) 
For (4) and (5) 
(a) R^ = CH^, R^ 
(b) R^ = CH^, R^ 
(c) R^ = CH^, R^ 
(d) R^ = CH3, R^ 
= CH3 
= ^2" 5 
= n Pr 
= nBu 
(e) R, = H, R^ = CH. 1 
(f) R^ = H, R2 = 
(g) R. = H, R^ = 
1^ 
(h) R- H, R, 
^2^5 
nPr 
nBu 
Ill 
More such deazaflavin derivatives have been prepared and 
were found to oxidise alcohols to corresponding 
8 9 
aldehydes/ketones. It has been observed ' that (6) 
oxidises alcohols under alkaline conditions to yield the 
corresponding carbonyl compound while getting reduced to 
dihydrodeazaflavins (7). 
O^H 
H3C 
B, 
HO-i-R ^ 
(7) 
Many more such derivatives have been prepared and 
the substitutent effects in the 5-deazaflavin series were 
examined in terms of the oxidising ability towards benzyl 
alcohol. It was found that in some cases the oxidation 
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of benzyl alcohol by 5-deazaflavin have been shown to 
recycle automatically. On this basis, some new moieties 
1112 have been synthesised ' containing both flavin and 
deazaflavin, and such compounds (8) were found to possess 
strong oxidizing power and constitute an efficient auto-
recyclic system. 
'^H 3 
(8) 
It is observed that the common feature of all such 
compounds is the conjugated double bond surrounded by 
carbonyl groups and/or imino groups which should be a 
crucial centre of coenzymes. A similar electron 
deficient conjugated double bond ispresent in 5-ylidene -
barbituric acid derivatives which are regarded as 
simplified models of 5-deazaflavins. The relationship 
between the oxidising ability and the structure of the 
model compound was investigated and it was found that the 
electron density at the carbon-carbon double bond was a 
critical factor for the oxidation. 
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Since barbituric acid (9) has two replaceable 
hydrogens at 5-position, a number of its 5-ylidene 
derivatives can be prepared by its condensation with 
R J^ R = H, CH^, alkyl or aryl 
(9) 
Thus a number of 5-ylidene barbituric acid 
13 
.derivatives (lOa-c) were synthesised as redox 
coenzyme models and used for oxidation of alcohols. 
0 
H^C 
CH 3 
0 
(lOa) (10b) 
/<^x/NO 2 
(lOc) 
5-Alkylidene derivatives were studied as redox 
coenzyme models; these derivatives possess a number 
of biological activities besides their utility in 
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making different types of other physiologically active 
raolecules. Thus alkylidene derivatives of type (11) 
14 15 
and (12) have been reported ' to possess 
herbicidal, insecticidal and acricidal activities as 
valuable pigments respectively. 
?2 ^  96^5 
(11) 
R = C2H5, PhCH2, alkyl 
R-i ~ CHT, C^Hr f n—CcH, 1 , 
phenyl 
R2 = H, CH^ 
^ H 
(12) 
R = -CH=CH2, 
-CH=CH-CH. 
-CH2-(CH2)4-CH3 
5-Ylidene compounds are themselves important 
intermediates for synthesising a variety of 
compounds. It has been found that barbituric acids 
when heated v^ ith triethylammonium formate (TEAF, 
prepared from formic acid and triethylamine) yielded 
5-methylbarbituric acids (13) via the formation of 
5,5-methylidene bis barbituric acid as shown in 
scheme-V. 
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H 
HCOON ( C ^ H ^ ) ^ 
-H2O HCOOH 
i 
+ 
(13) 
R = H, CH. 
(Scheme-v) 
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Another method for the synthesis of substituted 
barbituric acids (14) involves the reaction of 5-aryli-
denerbituric acid (15") with different Grignard type 
reagents (R-ZnBr) and subsequent acidic hydrolysis of the 
products. 
B 
R J^ 
(15) 
(l)R2ZnBr/THF 
(2) H30'^  
H 
(14) 
.18 
R = alkyl 
^1 " ^6"5^"2' ' •^"^"3'^6"4'' 2CH30CgH^-, 4-CH30CgH4-
R^ = CH2=CH-CH2- / CgH^ ^^2~' ^^3 
Pyranopyrimidine system (16) have been found"^" to 
be the outcome of 1,4-cycloaddition of phenylacetylene to 
the unsaturated intermediate viz, S-ylidenethiobarbituric 
acid derivative (formed from the aldehyde and the 
thiobarbituric acid) (Scheme VI). 
in 
Y 
R 
0 
Rj^CHO 
R 
HC=C-Ph 
Sx^N^^^g,Hg 
R = Alkyl or aryl 
R,= Aryl 
(Scheme - VI) 
Autorecycling oxidation of alcohol by pyrido-
dipyrimidine bound crosslinked polystyrenes has been 
carried out, where (17) was bound to chloromethylated 
styrene-divinyl benzene copolymer and used to oxidise 
19 
cyclopentanol to the ketone 
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Besides 5-deazaflavins, oxa-deazaflavins have also been 
synthesised. Compounds of such type (18 and 19) have 
been used as antiallergic, antihistaminic and serotonin 
HOH 
(18) (19) 
inhibiting agents 20, 
Object of Present Work 
The synthetic utility and biological activity of 5-
arylidene and 5-alkalylidene pyrimidines is well 
established. It was proposed that the synthetic 
reactivity of such molecules is due to the presence of a 
reactive >C = C<Jlanked by electron withdrawing groups. 
The proton attached to this yc=C<^ has shown a 
1 13 • 
characteric low field position in H-NMR spectra ' 
(ranging from ^ 8.5 to 9.6) implying that the 5-position 
is the most electron-deficient and very reactive to 
nucleophiles.' Besides, these compounds were studied as 
redox coenzyme models and have shown catalytic properties 
to oxidise alcohols to corresponding carbonyl compound as 
discussed earlier. Keeping this in viev/, and in conti-
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nuation of our earlier work on thiobarbituric acid, 
synthesis of some 5-ylidene thiobarbituric acids 
derivatives have been undertaken which can have the 
possibility to be used as redox coenzyme models. 
Present Work 
In order to synthesise different 5-ylidene thiobar-
bituric acids series of reactions were carried out which 
have been discussed in Part A, B, and C. 
PART A : 
The first series of reactions involves the 
synthesis of 1,3-diaryl-5-arylidene thiobarbituric acids 
C22arf). This was achieved by condensation of 
thiobarbituric acid (21) with substituted benzaldehydes 
in the presence of triethyl amine using benzene as the 
solvent. 
Synthesis of 1/3 — diaryl-5-arYlidene-2-thiobarbituric 
acids (22a-f) 
The reaction of 1,3-di(2-methylphenyl)-2-
thiobarbituricacid (21 a) with o-nitrobenzaldehyde in benzene 
in the presence of triethylamine gave a white solid. Its 
H-NMR spectra showed a singlet at ^2.15 for two methyl 
groups. Aromatic protons appeared as multiplets at 
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£7.25-8.15 integrated for twelve protons. Arylidene 
proton was observed at lower field S 8.65 showing its 
electron defficient position. In its mass spectrum, the 
molecular ion peak appeared at M 457 which corresponds to 
the molecular formula C-cH,QN,0 .S. On the basis of 
spectral analysis and elemental analysis the structure 
was formulated as l/3-di(2-methylphenyl)-5-(2-nitro-
benzylidene)_2-thiobarbituric acid (22a). Similarly the 
compounds (22b-f) were synthesised by the treatment of 
appropriate thiobarbituric acid with substituted 
benzaldehyde and identified fay spectral data and 
elemental analysis. 
Rr 
tH 
5v^-<P 
(21a-f) (22a-f) 
(a) 
(b) 
(c) 
(d) 
(e) 
(f) 
^1 
2-CH3 
H 
2-OCH. 
4-CH3 
4-Cl 
4-CH. 
^2 
0-NO. 
0-NO, 
0-NO, 
0-NO, 
P-NO, 
P-NO, 
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PART B 
This series involves the reaction of l,3-di(4-
bromophenyl)thiobarbituric acid (23a) with Vilsmeir 
reagent to give 6-chloro-1,3-•di(4-bromophenyl)-5-formyl-
2-thiouracil (24a) which was further reacted with 1,3-
diaryl thiobarbituric acids (23a-f) in benzene in 
presence of triethylamine to give the corresponding 
5-[6'-chloro-1',3'-di(4"-bromophenyl)-2'-thiouracil-5'-
yl] methylidene-1,3-diaryl-2-thiobarbituric acids 
(25a-f). 
Synthesis of 6-chloro-l,3-di(4-bromophenyl)-5-fonnyl-2-
thiouracil (24a) 
3-Di(4-bromophenyl)--?-thiobarbituric acid (23a) was 
treated with POCl^/DMF to give a yellow solid product. 
This compound showed the presence of chlorine and 
responded positively to DNP test indicating the 
introduction of an aldehyde group. The H-NMR spectrum 
of the above compound showed a singlet at i 9.90 for one 
proton, assigned to -CHO group, besides other usual 
signals. On the basis of spectral data and elemental 
analysis the structure was assigned as 6-chloro-l,3-
di(4-bromophenyl)-5-formyl-2-thiouracil(24a). 
Br 
Br 
V^xP 
(23a) 
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POCl-,/DMF 
(24a) 
Synthesis of 5-[6"-chloro-l' ,3•-di(4"-bro^nophenyl)-2"-
thiouracil-5 '-yl)-methylidene-1,3-diaryl-2-thiobarbituric 
acids (25a-f) 
As a test reaction, 6-chioro-l,3-di(4-bromophenyl) 
-5-formyl-2-thiouracil (24a) on condensation with 1,3-di 
(4-bromophenyl)-2-thiobarbituric acid (23a) in presence 
of triethylamine gave an orange coloured product. Its 
IR spectrum showed absorptions at 1690, 1650 cm for 
X^=0 groups. In the H-NMR spectrum, a multiplet 
integrating for 17 protons appeared at S6.8-7.65 which 
was assigned to resonance of methylidene proton 
merged with the multiplet of aromatic protons. 
On the basis of spectral data and elemental 
analysis the structure was established as 5-[6'-chloro-
1',3'-di(4"-bromophenyl)-2'-thiouracil-5'-yl]-methylidene 
1,3-di(4-bromophenyl)-2-thiobarbituric acids (25a). 
The other 5-(pyrimidinyl) methylidene-2-thiobar-
bituric acids (25b-f) were prepared in a similar manner 
and the structure was established on the basis of their 
spectral data and elemental analvsis. 
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( 2 4 a ) 
4-
(25 a-f; 
( 2 5 a - f ) 
( a ) 
( b ) 
( c ) 
( d ) 
( e ) 
( f ) 
R 
R 
R 
R 
R 
R 
= 
= 
= 
-
-
= 
A-Br 
2-OCH 
4 - C l 
2-CH3 
4-CH3 
H 
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PART C 
This series of reactions involves synthesis of 7,9-
diaryl pyrano (2,3-d:6,5-d) dipyrimidine-2(lH), 8(10H) 
dithioxo, 4 { 3 H ) , 5 { 7 H ) , dione (27a-f) by the reaction of 
6-chloro-l,3-diaryl-5-formyl-2-thiouracil (24a-f) with 
thiobarbituric acid (26). 
Synthesis of 7,9-diaryIpyrano (2,3-d:6,5-d)dipyrimidine-
2 (IH), 8(10H) dithioxo 4(3H) 6(7H), dione (27a-f) 
6-chloro-l / 3-dj4)romophenyl^5-f ormyl-2-thiouracil 
(24a) on reaction with unsubstituted thiobarbituric acid 
in presence of triethylamine in benzene gave a red 
coloured solid, which showed absence of chlorine and did 
not respond to the DNP test. Its IR spectrum showed 
absorption for NH function at 3412.1 cm and absorptions 
at 1687.5/ 1655.1 cm~ for>C=0 groups. In the H-NMR 
spectrum, the aromatic protons were observed as 
multiplet at S 7.0-7.7 integrating for 8 protons. A 
singlet for one proton appeared at <? 8.9 (D«0 
unexchangeable) assigned to 5-H. Its presence at lower 
field shows the electron defficient position comparable 
to the compounds (21a-f, PART A ) , while in (PART B 
25a-f) the singlet for methylidene proton was found 
merged in multiplet for aromatic protons, A broad 'Singlet 
for NH proton (DO exchangeable) was observed at 
i11.9. 
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On the basis of above spectral data and elemental 
analysis, the structure was established as 
7,9-diphenylpyrano (2,3-d : 6,5-d) dipyrimidine-2(IH), 
8(10H), dithioxo, 4(3H) 6(7H), dione (27a). Similarly the 
compounds (27b-f) were synrhesised and the structures 
were assigned on the basis of spectral data and elemental 
analysis. 
R-~. 
•R 
Sx^^x:i 
(X6) 
(27a-f) 
NH 
( a ) 
( b ) 
( c ) 
( d ) 
( e ) 
( f ) 
R 
R 
R 
R 
R 
R 
= 
= 
= 
= 
= 
= 
4 - B r 
H 
2-CH3 
3-CH3 
4-CH3 
4 - C l 
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EXPERIMENTAL 
1,3-diaryl thiobarbituric acids (21a-f) were synthesised 
following the procedure as described in previous 
chapters. 
Synthesis of 1,3 - diaryl-5-arylidene-2-thiobarbituric 
acids (22a-f) 
1,3-di{2-methylphenyl)-5-(2-nitrobenzylidene)-2-
thiobarbituric acids (22a) 
General Procedure 
1,3-di(2-methylphenyl)-2-thiobarbituric acid 
(21a, 3.24 g, 0.01 mol) and o-nitrobenzaldehyde (1.51g, 
0.01 mol) were refluxed in benzene (50 ml) in the 
presence of 3-4 drops of triethylamine for 30 min. 
Solvent was removed by distillation, washed with water 
and dil HCl^the solid thus obtained was fillered dried 
and crystallised from chloroform and methanol as white 
shining crystals of 22a (4.11 g, yield (89%) m.p. 1960C. 
UV X 
MeOH d o g e ) 
max 
I.R.I) S^a°' cm-l 
270 (nm) 
1650, 1605, 1520, 1375, 
1320, 1220, 1020, 740. 
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IH-NMR (CDCI3) S ' 2 . 1 5 ( 6 H , S , 2XCH3), 7 . 1 5 - 8 . 1 5 
(12H, m, Ar-H), 8.65 (IH, S, 
methylidene proton). 
Mass m/z :457(M*"), 442,396, 324, 309, 291, 
280, 241, 223, 159, 133, 91, 
79. 
Analysis : Calculated for C^ t-H, QN-,0 ,S : C, 
6 5-. 5; H, 4.1; N, 9.1. Found : 
C, 65'.8; H, 4.3; N, 9.3%. 
1,3-diphenyl-5- (2-nitrobenzylidene ) -2-t.hiobarbituric 
acids (22b) 
21b (2.98g, 0.01 mol) and o-nitrobenzaldehyde (1.51 g, 
0.01 mol) were condensed in benzene in presence of 
triethyl amine . Solid obtained on working up the 
reaction mixture, was recrystallised from chloroform 
and methanol as white crystals of 22b (3.8g, yield 
88%), m.p. 177-79°C. 
.R. n) ^ 3^°""" cm"-"- : 1650, 1610, 1500, 1400, 1380, 
1320, 1020, 740. 
max 
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^H-NMR (CDCI3) I : 7.15-8-20(14H, m, Ar-H), 8.65 
(IH, S, methylidene proton). 
Analysis : Calculated for C23'^15^3^4^ * ^' 
64.3; H, 5.3; N, 9.7. Found : 
C, 64.7; H, 5.5; N, 9.3%. 
1,3-di(2-methoxyphenyl)-5-(2-nitrobenzylidene)-2-
thiobarbituric acid (22c) 
21c (3.65g, 0.01 mol) was refluxed with nitro 
benzaldehyde (1.51 g, 0.01 mol) in benzene in presence 
of triethylamtne Solid obtained after working up the 
reaction was recrystalized from chloroform and methanol 
to give white crystals of 22C (4.1g, yield 83%(, m.p. 
160-61°C. 
I-R. ^ max°"'' ^^~'^ ' 1635, 1600, 1500, 1400, 1375, 
1320, 1020, 740. 
•""H-NMR (CDCI3) S : 3.8 (6H, S, 2XOCH2), 6.8-8.0 
(12H, m, Ar-H) 8.7 (IH, S, 
methylidene protone) 
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Analysis : Calculated for C2rH,QN^0gS : C, 
61.3; H, 3.8; N, 8.5. Found : 
C, 61.4; H, 3.6; N, 8.2%. 
1,3-di(4-methylphenyl)-5-(2-nitrobenzylidene)-2-
thiobaarbituric acids (22d) 
21d (3.24g, 0.01 mol) and o-nitrobenzaldehyde 
(1.51 g, 0.01 mol) were condensed in benzene in 
presence of triethylamine. Solid thus obtained after 
working up the reaction mixture was recrystallised 
from chloroform and methanol as white crystals of 22d 
(3.8g, yield 83%) m.p. 181-83°C. 
^•^« J^J^ i^ """ cm-1 : 1640, 1600, 1520, 1380, 1320, 
1220, 740. 
max 
•'•H-NMR (CDCl^)^ : 2.45 (6H, S, 2XCH2), ^'^ "^'^ 
(12H, m, Ar-H), 8.65 (IH, S, 
methylidene proton). 
Analysis : Calculated for C25H^QN^O.S : C, 
65.4, H, 4.1; N, 9.1. Found 
65.2; H, 4.3; N, 8.9%. 
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1,3-di(4-chloropheny1)-5-(4-ni trobenzylidene)-2-
thiobarbituric acids (22e) 
21e (3.64 0.01 mcl) and p-nitrobenzaldehyde (1.51 
g, 0.01 mol) were refluxed in benzene (50 ml) in the 
presence of 2-3 drops of triethylamine for 30 min. 
Solvent was concentrated and was allowed to cool down. 
The solid appeared was filtered, dried and was 
crystallised from chloroform and methanol as white 
solid of 22e (3.8 g# yield 80%) m.p. 233-35°C. 
U.V. /\ MeOH 
max 
(log£) • 270 nm 
T- „ .NUTOl -1 
I.R. ^ -^  cm 
max 
•"•H-NMR (CDCI3) S 
: 1635, 1600, 1515, 1380, 1320, 1250, 
750 
: 7.05-7.8 (12H, m, Ar-H) 8.45 
(IH, S, methylidene proton). 
Analysis Calculated for C2oH,^Cl2N^0.S : 
C, 55.5; H, 2.6; N, 8.4. Found 
: C,55.6; H, 2.7; N, 8.5%. 
1/3-di(4-methylphenyl)-5-(4-nitrobenzylidene)-2-
thiobarbituric acids (22f) 
21f (3.24 , 0.01 mol) and p-nitrobenzaldehyde 
(1.51 g, 0.01 mol) were condensed in benzene in the 
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presence of triethylamine using the same - method as in 
above case. The solid obtained was crystallised from 
chloroform and methanol as white crystals of 22f 
( 3.1 g, yield 70%) m.p. 222-24°C. 
MeOH U-'^ - ^mlx (log ) • 270 nm 
_ „ NUTOl -1 
I.R. -0 cm -^  
*'max 
1660, 1600, 1500, 1310, 700 
•H-NMR ( C D C I 3 ) S 2 . 4 5 (6H , S , 2XCH2), 7 . 0 5 - 7 . 8 
( 1 2 H , m, A r - H ) , 8 . 4 ( I H , S , 
m e t h y l i d e n e p r o t o n ) . 
Analysis Calculated for ^25^19^3^4^ * ^' 
65.*%; H, 4.1; N, 9.1. Found : 
C, 65.5; H, 4.1; N, 9.12%. 
PART B 
Synthesis of 6-chloro-l,3-di{ 4-bromophenyl)-5-f orTnyl-2-
thiouracil (24a) 
1,3-Di-(4-bromophenyl)-2-thiobarbituric acid 
(23a, 4.54, 0.01 mol) in dimethylformamide (11 ml) was 
cooled to 0°C in an ice-acetone bath. Phosphorous 
oxychloride (4.62 ml, 0.03 mol) was then added to it 
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dropwise, maintaining the temperature between 10-20°C. 
The reaction mixture was refluxed for 45 minutes. 
After cooling, it was poured over crushed ice and left 
overnight at room temperature. The solid thus obtained 
was filtered, dried and crystallised from methanol as 
yellow solid crystals of 24a (3.80g, yield 76%), m.p. 
110(d). 
"'•H-NMR (CDCI3) S : 7.15-7.7 (8H, m, Ar-H), 9.95 
(IH, S, CHO). 
Analysis : Calculated for C,^HQ Br2ClN202S 
: C, 40.8; H, 1.8 N, 5.6. 
Found : C, 41.1; H, 1.6; N, 
5.4%. 
5-(6•-chloro-1',3'-di(4"-bromophenyl)-2"-thiouracil-5'-
yl) methylidene-1,3-di(4-bromophenyl)2-thiobarbituric 
acid (25a) 
General Procedure 
6-Chloro-l,3-di{4-bromophenyl)-5-formyl-2-
thiouracil (24a, 0.5g, 0.001 mol) and 
1,3-di(4-bromophenyl)-2-thiobarbituric acid (23a, 0.45 
g, 0.001 mol) in benzene were refluxed for 30 min in 
133 
presence of triethylamine (0.2 ml). The solvent was 
distilled off and the residue was treated with crushed 
ice. The solid obtained was filtered; washed with dil 
HCl followed by water and dried. If was crystallised 
from chloroform-methanol as orange crystals of 25a 
(0.63 g, yield 674) m.p. 182-84°C. 
^ MeOH (265 nm) and (435 nm) 
Nujol -1 : 1690, 1650, 1585, 1375, 1060, 
I.R. '\) cm 
max 
1000 
"""H-NMR (CDCl^)^ 6.8-7.65 (17H, m, Ar-H and 
methylidene proton) . 
Analysis Calculated 
^33"l7^^4^1V3^2 
for 
C, 42.3; 
H, 1.8; N, 5.9. Found 
42.6; H, 2.0; N, 6.3. 
C, 
5-(6'-chloro-1*-3'-di(4"-bromopheny1)-2 "-thiouracil-5'-
y 1) methylidene-1, 3-di (2-methoxyphenyl) -2-thiobarbi-
turic acid (25b) 
24a (0.50 g, 0.001 mol) was refluxed with 
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l,5-di(2-methoxyphenyl)-2-thiobarbituric acid (23b, 
0.35 g, 0.01 mol) in benzene and triethylamine (0.2 ml) 
as base. The usual work up of the reaction mixture 
gave a soli.d, which on crystalisation from chloroform 
methanol, was obtained as orange crystals of 25b 
(d.S7 g, yield 66%), m.p. 212-15°C. 
.. .- . MeOH 
"•^* '^max (log£) 
(278 nm) and (440 nm) 
I R •S)NuJ°l cm-1 i . K . vn\ax c  1 6 8 5 , 1655 , 1590 , 1370, 1100, 
1060 , 1000 
"H-NMR (CDCl^) S 
Analysis 
3.8(6H, S, 2XOCH2), 6.6-7.8 
(17H, m,Ar-H and methylidene 
protone). 
Calculated for C^cH23Br2ClN.OcS-
: C, 50.1; H, 2.7; N, 6.6. 
Found : C, 49.8; H, 2.4; N, 
6.5%. 
5-[6•-Chloro-1',3 *-di(4"-bromopheny1)-2"-thiouraci1-5•-
yl) methylidene-l,3-di(4-chlorophenyl)-2-thiobarbituric 
acid (25c) 
24a (0.50 g, 0.001 mol) and 1,3-di(4-Chlorophenyl 
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2-thiobarbituric acid (23C/0.36g, 0.001 mol) were 
refluxed in benzene in presence of triethylamine (0.2 
ml) for 30 minutes. Working up of the reaction by the 
above procedure gave a yellovz-solid which 
recrystallised from chloroform-methanol as yellow 
flakes of 25C (0.50^ , yield 67%) m.p. 96-98°C (d). 
U.V. A^^^^» log£ 
max 
(270 nm) and (430 nm) 
I.R. -^ )^ 3^°''' ^" •'" = 1700, 1660, 1380, 1140, 1050, 
1000 
max 
"H-NMR (CDCl^) S : 6.86—7.7 (17H, m, Ar-H and 
methylidene proton). 
Analysis Calculated 
C33"l7^^2^l3V322 
for 
C, 46.8; 
H, 2.0; N, 6.5. Found : C, 
47.0; K, 2.3; N, 6.1. 
5-(6'-chloro-1',3'-di(4-bromophenyl)-2"-thiouracil-5-
yl)-methylidene-1,3-di(2-methylphenyl)-2-thiobarbituric 
acids (25d) 
24a (0.50 g, 0.001 mol) and 1,3-di(2-methylphenyl 
2-thiobarbituric acid (23d, 0.32 g. , 0.001 mol) in 
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benzene were refluxed for 30 min in presence of 
triethylamine (0.2 ml). Working up of the reaction 
gave a solid which was crystallised from chloroform-
methanol as orange crystals of 25d {0.55g, yield 68%), 
m.p. 170-73°C. 
„ „ -v MeOH ,, a ^ (274 nm) and (440 nm) 
.Nuiol -1 
I R M cm -•• 1690, 1660, 1595, 1370, 1060, 
1000. 
•""H-NMR (CDCI3) ^ 2.20 (6H, S, 2XCH2), 6.80-7.7 
(17 H, m, Ar-H and methylidene 
protone). 
Analysis Calculated for C^cHjoBr^ClN.0,S 
C, 52.1; H, 2.8; N, 6.9; Found 
: C, 52.3; H, 3.1; N, 7.1%. 
5-(6'-chloro-1',3'-di(4"-bromophenyl)-2'-thiouracil-
5'-yl) methylidene-1,3-di (4-methylphenyl)-2-thiobar-
bituric acid (25e) 
24a (0.50g, 0.001 mol) and 1,3-di(4-methyl 
phenyl)-2-thiobarbituric acid, 23e (0.32 g, 0.001 mol) 
were refluxed in benzene in presence of 0.2 ml 
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triethylamine for 30 min. The reaction mixture was 
worked up as in previous cases and the solid obtained 
was crystallised from chloroform methanol as orange 
solid of 25e (0.53 g, yield 65%) m.p. 230-33°C, 
U.V. A"®°"(ioge) '' ^2"^^ ""*' ^"^^ ''^^^ "^""^  
I.R. m^ax^ ""^  cm"-"- : 1690, 1665,1590, 1370, 1060, 
1000 
•H-NMR (CDCI3) S 
Analysis 
2.45 (6H, S, 2XCH3) 6.9-7.7 
(17 H, m, Ar-H and .methylidene 
protone). 
Calculated for C^cH^oBr-ClN.O^S2 
C, 52.1; H, 2.8; N, 6.9; Found 
: C, 52.4; H, 2.9; N, 7.1%. 
5-(6'-chloro-1',3•-di(4"-bromophenyl)-2'-thiouracil-5'-
yl) methylidene-l,3-diphenyl-2-thiobarbituric acid 
(25f) 
24a (0.5g, .001 mol) and 1,3-diphenyl-2-thio-
barbituric acid, 23f (0.2 9 g, 0.001 mol) refluxed in 
benzene in presence of D. 2 ml of triethylamine for 30 
min. Solid obtained after working up the reaction 
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mixture as usual was crystallised from chloroform 
methanol as orange crystals of 25f (D.49 g, yield 66%) 
m.p. 208-10°C. 
U,V. A (3oge) 
max ^ 
(265 nm) and (440 nm) 
i-x- <ti°' - - 1 1690, 1660, 1590, 1375, 1055, 1000 
"H-NMR (CDCl^)S 6.85-7.7 (19 H, m, Ar-H and 
methylidene protone). 
Analysis Calculated for C^^H,QBr2ClN.0^82 
C,53.0; H,2.5; N,7.5 ; Found : C, 
53.1; H, 2.4; N, 7.4. 
PART C 
6-Chloro-l,3-diaryl-5-formyl-2-thiouracil (24a,b, 
e,f) were prepared following the method as described in 
chapter III. 
6-Chloro-l,3-di(2-methylphenyl)-5-formyl-2-thiouracil 
(24c) 
1,3-(2-methylphenyl)-2-thiobarbituric acid (3.2 
g, 0.01 mol) in dimethylformanide (11 ml) was cooled to 
0°C in an ice-acetone baths. Phosphorous oxychloride 
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(4.62 ml, 0.03 mol) was then added to it dropwise, 
maintaining the temperature between 10-20°C. The 
reaction mixture was refluxed for 45 min. After 
coding, it was poured over crushed ice and left 
overnight at room temperatures. The solid thus 
obtained was filtered, dried and crystallised from 
benzene petrol as yellow crystals of 24c {2.5g, yield 
67%) m.p. 101°C (d). 
•"•H-NMR (CDCl^) B : 2.3 (6H, S, 2xCH2) , 6.5-7.7 
(8H, m, Ar-H), 10.1 (IH, S, 
CHO) . 
Analysis : Calculated for C,gH,CCIN2O2S : 
C, 61.6; H, 4.0; N, 7.5; Found 
: C, 61.3; H, 4.2; N, 7.2%. 
7,9-di (4-bromophenyl)pyrano (2,3-d: 6,5-^dipyrimidinet-2-
(IH), 8(10H) dithioxo, 4(3H), 6(7H), dione (27a) 
General Procedure 
6-Chloro~l,3-Qi(4-bromophenyl)-5-formyl-2-
thiouracil (24a, 5.0 g, 0.01 mol) and thiobarbituric 
acid (26, 1.16g, 0.01 mol) v/ere dissolved in benzene 
(100 ml) in presence of triethylamine 0.3 ml and few 
drops of methanol and refluxed for 30 min. The solvent 
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was distilled off and water was added into the residue. 
The solid obtained was filtered, washed with dil HCl 
followed by water and dried. It was crystallised from 
benzena-petrol as red crystals of 27a (4.8g, yield 81%) 
m.p. > 300°C. 
U.V. /''^^" (log ^ ) : 233, 307, 473, 513 nm 
F.T. I.R. ^ kBr cmTl 3412.1, 1687.5, 1655.1, 1618.0, 
m3.x 
1527.8, 1486.5, 1187.1, 1012.3, 
• 799.5 
•^ H-NMR (CDCl2+DMS0'^6)S 7.0-7.7 ( 8H, m, Ar-H), 8.9 
(IH, S, 5-H),11.9 (IH, br-S, 
NH, D_ 0 exchangeable). 
Analysis : Calculated for C2TH,QBr2N.0,82 
: C, 42.7; H, 1.6; N, 9.4. 
Found. C, 42.9; H, 1.9; N, 
9.8%. 
7,9-di(phenyl)pyrano(2,3-d; 6,5--d)dipyrimidine-2-(IH) , 
8(10H) dithioxo, 4(3H), 6(7H) dione (27b) 
24C (5.0g, 0.01 mol) and thiobarbituric acid (26, 
l.lg, 0.01 mol) were condensed in presence of 
triethylamine (3-4 drops) following the same procedure 
as above. Red solid was obtained which was 
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crystals of 27b (3.4g, yield 78%), m.p. >300°C. 
I.R. -0 ^^i^-^ cm"^ : 3400, 1690, 1650, 1580, 1370 
•"•H-NMR (CDCI3) S : 7.0-7.7 (lOH, m, Ar-H), 9.2 (IH, 
S, 5-H). 
Analysis : Calculated for C21^12^4^3^2 * 
C, 58.3; H, 2.7; N, 12.9. 
Found : C, 58.5; H, 2.5; N, 
13.1%. 
7-9-di (2-methylphenyl) pyrano (2,3-d; 6,5-d) dipyrimidine-
2-(lH), 8(10H) dithioxo, 4(3H), 6(7H) dione (27C) 
24C (3.7g, 0.01 mol) and thiobarbituric acid (26, 
l.lg, 0.01 mol) were refluxed in similar condition as 
in typical case for 30 min. Working up of reaction 
gave red solid which on recrystallisation gave red 
crystals of 27d (3.4g, yield 69%), m.p. > 300°C. 
"""H-NMR (CDCl^+DMSO^g)^: 2.3 (6H, 3, 2XCH3) , 7.0-7.6 
(8H, m, Ar-H), 8.8 (IH, S, 5-H) 
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Analysis : Calculated for C23Hj^gN^03S2 : 
C, 60.0; H, 3.4; N, 12.17. 
Found : C, 60.1; H, 3.5; N, 
12.1%. 
7, 9-di ( 3-methylphenyl) pyrano (2,3-d ; 6 , 5-d )dipyriinidine-2-
(IH), 8(10H) dithioxo, 4(3H), 6(7H) dione (27d) 
24d (3.7g, 0.01 mol) and the barbituric acid (26, 
l.lg, 0.01 mol) were condensed following the same 
procedure as above to give red solid which on 
recrystallisation from chloroform-methanol give red 
crystals of 27e (3.0 g yield 67%), m.p. > 3G0°C. 
•'•H-NMR(CDCl2+TFA) S : 2.3 (6H, S, 2xCH2) : 6.8-7.6 
(8H, m, Ar-H) 8.9(1H, S, 5-H). 
Analysis : Calculated for Co-jH, ^ N .0-,S- : 
23 16 4 3 2 
C, 60.0; H, 3.4; N, 12.1. 
Found : C, 60.2; H, 3.3; N, 
12.3%. 
7, 9-di ( 4-methyIphenyl)pyrano( 2 ,3-d; 6,5-d)dipyrimidine-
2-(lH), 8(10H) dithioxo, 4(3H), 6(7H) dione (276) 
24e (3.7g, 0.01 mol) and thiobarbituric acid (26, 
l.lg, 0.01 mol) were condensed following the same 
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procedure to give red solid which on recrystallisation 
from chloroform-methanol gave red crystals of 27e 
(3.1g, yield 61%), m.p. >300°C. 
-••H-NMR (CD3OD) 8 : 2.3(6H, S, 2XCH3), 1 .Q-1.1 (8H, 
m, Ar-H), 8.7 (IH, S, 5-H), 
Analysis : Calculated for ^23^16^4*^3^? ' 
C, 60.0; H, 3.4; N, 12.1. Found 
: C, 60.2; H, 3.5; N, 12.2%. 
7,9-di(4-chloropheny1)pyrano(2,3-d:6,5-d)dipyrimidine-
2-(lH), 8(10H) dithioxo, 4(3H), 6(7H) dione (27f) 
24f (4.7g, 0.01 mol) and thiobarbituric acid, 26 
(l.lg, 0.01 mol) were condensed following the same 
procedure to give red solid which on crystallisation 
from chloroform-methanol gave red crystals of 27f 
(i.5g, yield 79%) m.p. >300°C. 
•"•H-NMR (CDCI3) S : 7.1-7.7 (8H, m, Ar-H) 9.1 (IH, 
S, 5-H). 
Analysis : Calculated for C_,H, ^ Cl^ .N .0-,S« 
^± lU ^ 4 J 2 
: C, 50.4; H. 2.0; N, 11.2. 
Found : C, 50.5; H, 2.1; N, 
11.1 
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